Query 012822
Match_columns 456
No_of_seqs 264 out of 1881
Neff 10.5
Searched_HMMs 46136
Date Fri Mar 29 06:40:22 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/012822.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/012822hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 COG0534 NorM Na+-driven multid 100.0 4.8E-53 1E-57 410.1 51.5 408 44-455 12-423 (455)
2 PRK00187 multidrug efflux prot 100.0 1.7E-49 3.8E-54 389.0 52.8 410 43-455 4-424 (464)
3 PRK10189 MATE family multidrug 100.0 9.8E-49 2.1E-53 383.6 53.6 409 44-455 24-442 (478)
4 PRK09575 vmrA multidrug efflux 100.0 2.9E-47 6.3E-52 372.7 50.1 405 45-455 8-416 (453)
5 PRK01766 multidrug efflux prot 100.0 7.1E-47 1.5E-51 371.9 52.2 410 43-455 6-422 (456)
6 PRK10367 DNA-damage-inducible 100.0 2.8E-46 6.1E-51 362.9 50.3 401 45-455 5-411 (441)
7 TIGR00797 matE putative efflux 100.0 1.1E-36 2.5E-41 289.0 43.9 338 57-397 1-341 (342)
8 TIGR01695 mviN integral membra 100.0 1.8E-34 3.8E-39 288.2 48.3 392 51-454 2-407 (502)
9 TIGR02900 spore_V_B stage V sp 100.0 3E-34 6.4E-39 285.7 45.0 394 52-454 2-413 (488)
10 KOG1347 Uncharacterized membra 100.0 2.1E-34 4.6E-39 277.2 32.1 409 45-455 24-432 (473)
11 PRK15099 O-antigen translocase 100.0 4.3E-32 9.3E-37 263.9 43.1 385 51-454 3-391 (416)
12 PF03023 MVIN: MviN-like prote 100.0 1.9E-27 4.1E-32 231.5 46.8 364 79-453 5-381 (451)
13 COG0728 MviN Uncharacterized m 100.0 2.4E-26 5.2E-31 219.6 48.1 392 49-446 7-410 (518)
14 PRK10459 colanic acid exporter 100.0 1.5E-25 3.3E-30 223.0 44.2 376 49-453 5-383 (492)
15 COG2244 RfbX Membrane protein 99.9 5.4E-24 1.2E-28 211.3 39.0 381 47-447 4-386 (480)
16 PRK00187 multidrug efflux prot 99.9 2.1E-21 4.5E-26 190.7 26.2 208 42-250 229-443 (464)
17 COG0534 NorM Na+-driven multid 99.9 1.7E-20 3.6E-25 182.7 27.2 210 40-251 232-443 (455)
18 PRK10189 MATE family multidrug 99.9 2.6E-20 5.6E-25 183.1 27.7 212 43-255 253-466 (478)
19 PRK01766 multidrug efflux prot 99.9 1.7E-20 3.6E-25 184.9 26.2 208 43-251 233-442 (456)
20 PRK09575 vmrA multidrug efflux 99.9 9.6E-20 2.1E-24 178.7 26.3 207 42-251 227-436 (453)
21 TIGR01695 mviN integral membra 99.8 2.2E-18 4.7E-23 172.4 31.5 206 44-251 218-428 (502)
22 PRK10367 DNA-damage-inducible 99.8 3.5E-18 7.5E-23 166.5 24.0 186 267-454 6-191 (441)
23 PF01943 Polysacc_synt: Polysa 99.8 4.2E-16 9.1E-21 142.9 33.2 269 52-338 2-272 (273)
24 PF03023 MVIN: MviN-like prote 99.8 5.1E-16 1.1E-20 151.5 30.2 206 44-251 193-403 (451)
25 PF01554 MatE: MatE; InterPro 99.8 2E-18 4.2E-23 145.2 8.6 162 278-441 1-162 (162)
26 TIGR02900 spore_V_B stage V sp 99.8 2.9E-16 6.2E-21 156.5 24.7 204 43-251 219-434 (488)
27 PF01554 MatE: MatE; InterPro 99.7 3E-18 6.5E-23 144.1 6.0 160 57-217 1-162 (162)
28 COG0728 MviN Uncharacterized m 99.7 4.1E-14 8.9E-19 136.1 34.8 206 44-251 227-437 (518)
29 PRK10459 colanic acid exporter 99.7 2.3E-14 5.1E-19 142.8 33.7 201 44-250 202-404 (492)
30 PRK15099 O-antigen translocase 99.7 1.2E-14 2.7E-19 141.5 26.2 202 42-250 208-411 (416)
31 TIGR00797 matE putative efflux 99.7 8E-15 1.7E-19 139.2 21.2 174 278-454 1-176 (342)
32 PF13440 Polysacc_synt_3: Poly 99.6 1E-12 2.3E-17 118.8 31.2 247 68-338 3-251 (251)
33 COG2244 RfbX Membrane protein 99.6 3.2E-13 6.9E-18 134.3 25.7 187 44-236 208-396 (480)
34 PF04506 Rft-1: Rft protein; 99.1 1.1E-07 2.3E-12 94.1 29.6 400 52-454 4-449 (549)
35 KOG2864 Nuclear division RFT1 99.1 4.6E-07 9.9E-12 83.9 29.6 396 48-454 7-428 (530)
36 KOG1347 Uncharacterized membra 99.1 6.3E-09 1.4E-13 101.2 18.0 184 266-453 24-208 (473)
37 PF07260 ANKH: Progressive ank 99.1 1.1E-06 2.3E-11 78.1 29.3 313 46-369 8-342 (345)
38 PF14667 Polysacc_synt_C: Poly 98.6 1.1E-05 2.3E-10 66.1 18.2 79 171-251 2-80 (146)
39 PF04506 Rft-1: Rft protein; 98.5 4.3E-05 9.2E-10 75.9 22.0 203 48-251 252-470 (549)
40 COG4267 Predicted membrane pro 98.2 0.005 1.1E-07 56.3 29.3 322 97-445 72-415 (467)
41 KOG2864 Nuclear division RFT1 97.9 0.0014 3E-08 61.5 18.2 200 50-251 240-449 (530)
42 PF01943 Polysacc_synt: Polysa 97.5 0.00058 1.3E-08 62.2 9.8 72 44-116 200-272 (273)
43 PF07260 ANKH: Progressive ank 97.3 0.063 1.4E-06 48.5 18.8 154 267-430 8-168 (345)
44 PF13440 Polysacc_synt_3: Poly 96.6 0.4 8.6E-06 42.8 18.8 121 295-431 10-131 (251)
45 PF14667 Polysacc_synt_C: Poly 96.2 0.011 2.4E-07 48.2 5.8 58 393-453 1-58 (146)
46 PF04505 Dispanin: Interferon- 73.6 24 0.00052 25.3 6.9 41 324-364 33-73 (82)
47 COG4267 Predicted membrane pro 60.9 1.6E+02 0.0034 28.2 13.5 117 124-247 321-438 (467)
48 PF02487 CLN3: CLN3 protein; 44.9 41 0.00089 32.5 5.0 31 41-71 235-265 (402)
49 COG4176 ProW ABC-type proline/ 32.5 3.8E+02 0.0083 24.3 8.6 72 164-235 91-165 (290)
50 PF05313 Pox_P21: Poxvirus P21 31.6 2.8E+02 0.006 23.3 7.0 27 225-251 135-161 (189)
51 KOG0054 Multidrug resistance-a 26.8 1E+03 0.023 27.5 23.0 34 303-336 456-489 (1381)
52 KOG2468 Dolichol kinase [Lipid 25.7 6.5E+02 0.014 24.7 9.8 38 318-355 412-449 (510)
53 PRK10739 putative antibiotic t 24.6 4.5E+02 0.0098 22.5 8.8 54 332-389 21-74 (197)
54 PRK09669 putative symporter Ya 23.9 6.8E+02 0.015 24.3 24.4 47 49-95 9-58 (444)
55 PF04505 Dispanin: Interferon- 23.0 2.9E+02 0.0063 19.7 5.5 31 111-141 42-72 (82)
No 1
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=100.00 E-value=4.8e-53 Score=410.12 Aligned_cols=408 Identities=26% Similarity=0.378 Sum_probs=383.9
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcc
Q 012822 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYE 123 (456)
Q Consensus 44 ~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~ 123 (456)
.++..|+++++++|++++++...+++.+|+.++||+|++++++.+++.++.. +...+..|++.|..+.++|++|+||++
T Consensus 12 ~~~~~k~l~~la~P~i~~~l~~~l~~~vD~~~vG~~~~~alaav~la~~i~~-~~~~~~~gl~~g~~~liaq~~Ga~~~~ 90 (455)
T COG0534 12 FKKILKLLLKLAIPIILGNLLQTLYGLVDTFMVGHLGAEALAAVGLANPIFF-LIIAIFIGLGTGTTVLVAQAIGAGDRK 90 (455)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccHHHHHHHHHHHHHHH-HHHHHHHHHHHhHHHHHHHHHcCCchH
Confidence 5567899999999999999999999999999999999999999999999999 899999999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHH
Q 012822 124 MLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAY 202 (456)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 202 (456)
++++..++++.++++++++..++ +.+.++++.+++.++++.+.+.+|+++..++.|+..++...++.+|+.||+|.+++
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ll~~l~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~m~ 170 (455)
T COG0534 91 KAKRVLGQGLLLALLLGLLLAILLLFFAEPLLRLLGAPAEVLELAAEYLRIILLGAPFALLSFVLSGILRGLGDTKTPMY 170 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCchhHH
Confidence 99999999999999999777754 89999999999998889999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHh-hC-CccchhHHHHHHHHHHHHHHHHHHHHhccc-ccccccCCChhhHhhHHHHHHHHhHH
Q 012822 203 ISAATLVLHLLLSWLVVYK-FG-AGLIGASLVLSLSWYIIVGAQFAYILMSDK-CKHTWTGFSVQAFSGICEFLKLSGSS 279 (456)
Q Consensus 203 ~~~~~~~~~i~l~~~li~~-~~-~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~p~ 279 (456)
.++++.++|+++|+++++. ++ +|+.|+++||++++++..++.++++.++++ ......+..+.+++.+|++++.|+|.
T Consensus 171 ~~~~~~~lNivln~llI~g~~g~lGv~GAA~AT~ia~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lG~p~ 250 (455)
T COG0534 171 ILLLGNLLNIVLNYLLIFGLFGGLGVAGAALATVIARWIGALLLLIYLLRKKRLLSLFKKKLLKPDRKLLKEILRLGLPI 250 (455)
T ss_pred HHHHHHHHHHHhhHHHHHhccccccchhHHHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhccCCCHHHHHHHHHhcccH
Confidence 9999999999999999998 57 999999999999999999999999998854 22222223233347799999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHH
Q 012822 280 AVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISF 359 (456)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (456)
++++..+...+...+.+++++|+ .++++|+++.++.++..+++.+++++..|.+++++|+||+|++++..+.++.++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~G~--~~lAa~~i~~~i~~~~~~~~~gi~~a~~~lvG~~~Ga~~~~~a~~~~~~~~~~~~ 328 (455)
T COG0534 251 FLESLSESLGFLLLTLFVARLGT--VALAAYGIALRIASFIFMPPFGIAQAVTILVGQNLGAGNYKRARRAARLALKLSL 328 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCh--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHH
Confidence 99999999999999999999995 4567999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHHHHH
Q 012822 360 IISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGIPLG 439 (456)
Q Consensus 360 ~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l~ 439 (456)
.+++..++.+++++++++++|++|+++.+.+..++++..+..++++.+.+..+.++|.||+|.++..++.++|.+.+|+.
T Consensus 329 ~~~~~~~~i~~~f~~~i~~lF~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~g~lrg~g~~~~~~~~~~~~~~~~~lp~~ 408 (455)
T COG0534 329 LIALLIALLLLLFREPIISLFTTDPEVIALAVILLLIAALFQPFDGIQFVLSGVLRGAGDAKIPFIISLLSYWGFRLPLA 408 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHhHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCcceeec
Q 012822 440 CLLGFKFNFGAKVKIR 455 (456)
Q Consensus 440 ~~l~~~~~~G~~G~~~ 455 (456)
+++.+.. +|..|+|.
T Consensus 409 ~~l~~~~-~g~~Gvw~ 423 (455)
T COG0534 409 YLLGFFF-LGLAGVWI 423 (455)
T ss_pred HHHhhhc-ccchHHHH
Confidence 9999986 79999984
No 2
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=100.00 E-value=1.7e-49 Score=388.96 Aligned_cols=410 Identities=25% Similarity=0.324 Sum_probs=373.5
Q ss_pred HHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 012822 43 ASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (456)
Q Consensus 43 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~ 122 (456)
++++..|++++.++|.+++++...+.+.+|+.+++|+|++++++++++.++.+ +...+..|++++..+.++|++|++|+
T Consensus 4 ~~~~~~k~il~~a~P~~~~~~~~~~~~~~d~~~v~~lg~~alAa~~i~~~i~~-~~~~~~~gl~~~~~~i~aq~~Ga~~~ 82 (464)
T PRK00187 4 PPTTELKAILRLAGPLIASQLAHMLMVFTDTLMMGRLGPEALAGGGLGAASYS-FVSIFCVGVIAAVGTLVAIRHGAGDI 82 (464)
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhcCCCh
Confidence 34567899999999999999999999999999999999999999999999999 77888899999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHH
Q 012822 123 EMLGVYMQRATFVLLATGVPVMMVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAY 202 (456)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 202 (456)
|++++..+.++.+.++++++..++..+.++++.+++.|+++.+.+..|+++..++.++..+....++++|+.|+++.+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~ev~~~~~~Yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~~ 162 (464)
T PRK00187 83 EGATRLAQAGLWLAWLLALVAALLLWNLKPLLLLFGQAPQNVDAAMQFLHLLPFALPGYLSFMALRGFTSALGRAGPVMV 162 (464)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcHHHHH
Confidence 99999999999999999888776655779999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhh----CCccchhHHHHHHHHHHHHHHHHHHHHhccccc-cc-ccCCChhhHhhHHHHHHHH
Q 012822 203 ISAATLVLHLLLSWLVVYKF----GAGLIGASLVLSLSWYIIVGAQFAYILMSDKCK-HT-WTGFSVQAFSGICEFLKLS 276 (456)
Q Consensus 203 ~~~~~~~~~i~l~~~li~~~----~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~ 276 (456)
.++++.++|+++++++++.+ ++|+.|+++|+.+++....+...++++++++.+ .+ +++..+.+++.+|++++.+
T Consensus 163 ~~~~~~~~ni~~~~~lIfg~~g~p~~Gv~Gaalat~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~lg 242 (464)
T PRK00187 163 ISLAGAVANLLLNYALIEGWFGLPKLGLMGIGLVTALVSNGMALALALYIRRHPAYAAYPLRKGLSRPSRAALRELWRLG 242 (464)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCccccccchHHHHHHHHHHHHHHHHHHHHhcchhhhhhhhccccCCCHHHHHHHHHhh
Confidence 99999999999999999763 389999999999999888877766666542221 11 1112223346699999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHH
Q 012822 277 GSSAVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTS 356 (456)
Q Consensus 277 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 356 (456)
+|.+++++.+...+.+++.+++++|+ .+++++++++++..+..++..+++++..+.++|++|+||.|++++..|.++.
T Consensus 243 ~P~~~~~~~~~~~~~i~~~~i~~~G~--~alAa~~i~~~i~~l~~~~~~gi~~a~~~lvgq~~Ga~~~~~~~~~~~~~l~ 320 (464)
T PRK00187 243 LPIGGTYAVEVGLFTFAALCMGALGS--TQLAAHQIALQIVSVAFMVPVGLSYAVTMRVGQHYGAGRLLEARRAGRVGIG 320 (464)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHcCH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHH
Confidence 99999999999999999999999985 4566999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHhhhhhhhcccC--cH---HHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHH
Q 012822 357 ISFIISVVFAVIVLALRHVISYAFTS--GE---VVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACY 431 (456)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~i~~l~~~--~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~ 431 (456)
+..+++++.+++++++++++.++|++ |+ ++.+.+..++++.+++.++++++.+..+++++.||+|.++++++.+.
T Consensus 321 ~~~~~~~~~~~~~~~f~~~i~~~ft~~~~~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~~~lrg~G~~~~~~~~~~~~~ 400 (464)
T PRK00187 321 FGAVVMLLFAGLFWLLPEAIIGLFLDRNDPAFAEIVQLAVSLLAVAAWFELFDGTQTIAMGAIRGLKDARTTFLIGLACY 400 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHcCCCCCccHHHHHHHHHHHHHHHHHHHhhHHHHHHHHhHhccCccHHHHHHHHHHH
Confidence 99999999999999999999999964 43 67888999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhhcCCCcceeec
Q 012822 432 YIVGIPLGCLLGFKFNFGAKVKIR 455 (456)
Q Consensus 432 ~~~~i~l~~~l~~~~~~G~~G~~~ 455 (456)
|++++|+.+++.+++++|+.|+|.
T Consensus 401 ~~~~ipl~~ll~~~~~~g~~Gvw~ 424 (464)
T PRK00187 401 WLVGAPLAWLLAFTLGWGAVGVWW 424 (464)
T ss_pred HHHHHHHHHHHHhccCCCceeeHH
Confidence 999999999999988999999984
No 3
>PRK10189 MATE family multidrug exporter; Provisional
Probab=100.00 E-value=9.8e-49 Score=383.61 Aligned_cols=409 Identities=16% Similarity=0.178 Sum_probs=373.5
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcc
Q 012822 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYE 123 (456)
Q Consensus 44 ~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~ 123 (456)
+-+..|++++.++|.++++++..+.+.+|+.+++++|++++++++++.++.. +...+..|++++..+.++|++|++|+|
T Consensus 24 ~~~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~lG~~alAA~~i~~~i~~-~~~~~~~gl~~g~~~lvsq~~Ga~~~~ 102 (478)
T PRK10189 24 RVLFWREITPLAVPIFIENLCVLLMGVLSTFLVSWLGKEAMAGVGLADSFNM-VIMAFFAAIDLGTTVVVAFSLGKRDRR 102 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhcCCCHH
Confidence 3456899999999999999999999999999999999999999999999998 888899999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcC--CCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhH
Q 012822 124 MLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLG--ESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPS 200 (456)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~--~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~ 200 (456)
++++..+.++.+++.++++.+++ +.+.++++.+++ .|+++.+.+..|+++..++.++..+....++++|+.||++.+
T Consensus 103 ~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ll~l~~~~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~ 182 (478)
T PRK10189 103 RARAAARQSLVIMTLFAVLLAVLIHFFGEQIIDLVAGDATPEVKALALTYLELTVWSYPAAAITLIGSGALRGAGNTKIP 182 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHhCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCchHHh
Confidence 99999999999999999888865 778889998884 689999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHhh----CCccchhHHHHHHHHHHHHHHHHHHHHhc-c-cccccccC-CChhhHhhHHHHH
Q 012822 201 AYISAATLVLHLLLSWLVVYKF----GAGLIGASLVLSLSWYIIVGAQFAYILMS-D-KCKHTWTG-FSVQAFSGICEFL 273 (456)
Q Consensus 201 ~~~~~~~~~~~i~l~~~li~~~----~~g~~g~~~a~~i~~~i~~~~~~~~~~~~-~-~~~~~~~~-~~~~~~~~~~~~~ 273 (456)
+..+++..++|+++++++++.+ ++|+.|+++|+.+++++..++..+++.++ + ..+.++++ +...+++.+|+++
T Consensus 183 ~~i~~~~~~~ni~l~~~li~g~~~~~~lGv~Gaa~At~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il 262 (478)
T PRK10189 183 LLINGGMNILNIIISSILIYGLFSWQGLGFVGAGLGLTISRYIGAVAIIWVLMIGFNPALRISLKSYFKPLNFAIIWEVM 262 (478)
T ss_pred HHHHHHHHHHHHHHhHHHHhcCCCCCccchHHHHHHHHHHHHHHHHHHHHHHHhccCccceeeeccccccCCHHHHHHHH
Confidence 9999999999999999999763 68999999999999999988876666543 1 12222221 1112346799999
Q ss_pred HHHhHHHHHHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHH
Q 012822 274 KLSGSSAVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVV 353 (456)
Q Consensus 274 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~ 353 (456)
+.|+|.+++.........+.+.+++.+|+ .++++|+++.++.++..++..+++++..|.+++++|++|.+++|+..+.
T Consensus 263 ~iG~P~~~~~~~~~~~~~~~~~~~~~~G~--~~~Aa~~I~~~i~~~~~~~~~gi~~A~~~lvg~~~Ga~~~~~a~~~~~~ 340 (478)
T PRK10189 263 GIGIPASIESVLFNGGKLLTQMFVAGMGT--SVIAGNFIAFSIAALINLPGNALGSASTIITGTRLGKGQIAQAERQLRH 340 (478)
T ss_pred HHhccHHHHHHHHHHHHHHHHHHHHHcCH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHHHHHHHHH
Confidence 99999999999999888888888899885 4567999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHH
Q 012822 354 VTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYI 433 (456)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~ 433 (456)
+.++...+++..+++++++++++.++|++|+++.+.+..++++.++..++++.+.+..+.++|.||++.++++++.+.|+
T Consensus 341 ~~~~~~~~~~~~~~l~~~~~~~i~~lFt~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~g~lrg~G~t~~~~~i~~~~~~~ 420 (478)
T PRK10189 341 VFWLSTLGLTAIAWLSAPFAGLLASFYTQDPDVKHVVKILIWLNALFMPIWAASWVLPAGLKGARDARYAMWVSMLGMWG 420 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHhhcCCCchHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhhcCCCcceeec
Q 012822 434 VGIPLGCLLGFKFNFGAKVKIR 455 (456)
Q Consensus 434 ~~i~l~~~l~~~~~~G~~G~~~ 455 (456)
+.+|+.+++....++|+.|+|.
T Consensus 421 v~ip~~~ll~~~~~~g~~Gvw~ 442 (478)
T PRK10189 421 CRVVAGYILGIMLGFGVVGVWM 442 (478)
T ss_pred HHHHHHHHHHHHhCCCHHHHHH
Confidence 9999999999888899999984
No 4
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=100.00 E-value=2.9e-47 Score=372.75 Aligned_cols=405 Identities=16% Similarity=0.202 Sum_probs=369.8
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcc
Q 012822 45 WLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHL-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYE 123 (456)
Q Consensus 45 ~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~ 123 (456)
++..|++++.++|.+++++...+++.+|+.+++++ |++++++++++.++.. +...+..+++.+..+.++|++|++|+|
T Consensus 8 ~~~~k~i~~l~~P~~~~~l~~~l~~~~d~~~lg~~~g~~~laa~~~~~~~~~-~~~~~~~~~~~g~~~lvsq~~Ga~~~~ 86 (453)
T PRK09575 8 QSIYRTFWRYTIPSIAAMLVNGLYQIVDGIFIGHYVGAEGLAGINMAWPVIG-IILGIGLMVGMGTGSLLSIKRGEGDLE 86 (453)
T ss_pred CchHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccccHHHHHHHHHHHHHHH-HHHHHHHHHhccHHHHHHHHhcCCCHH
Confidence 45678999999999999999999999999999996 9999999999999999 777888999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHH
Q 012822 124 MLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAY 202 (456)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 202 (456)
+.++..+.+..++.+++++..++ ..+.++++.+++.|++..+.+.+|+++..++.++..+.......+|+.|+++.+++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~~~~~~~~~yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~~ 166 (453)
T PRK09575 87 KAKRILTTGLLLLLLLGPIVSVILFLFADDFLRAQGAEGRTLELALQYIQVLIWGCLFTLGAIALPFLLRNDESPNLATG 166 (453)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 99999999999999999888865 78899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhcccc-cccccCCChhhHhhHHHHHHHHhHHHH
Q 012822 203 ISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKC-KHTWTGFSVQAFSGICEFLKLSGSSAV 281 (456)
Q Consensus 203 ~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~p~~~ 281 (456)
.++.+.++|+++++++++.+++|+.|+++|+++++++..++.+++++++++. +.+.+.++ .+++.+|++++.|+|..+
T Consensus 167 ~~~~~~~~ni~l~~~li~~~~~Gi~Gaa~At~is~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~il~ig~P~~~ 245 (453)
T PRK09575 167 LMVIGALINIVLDYLFIGWLDWGLTGAAIATALAQLVVTVLGLGYFFSSRANIRLTLKELR-FNWSLAPKIVLLGSSSFF 245 (453)
T ss_pred HHHHHHHHHHHhhHHHHHhCCchhHHHHHHHHHHHHHHHHHHHHHHHCCCceeEEeeccCC-cCHHHHHHHHHhChhHHH
Confidence 9999999999999999988889999999999999999999888777655322 21112222 234668999999999999
Q ss_pred HHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHH
Q 012822 282 MLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFII 361 (456)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (456)
+...........+.+++++|+ +.++++|+++.++..+..++..+++++..|.+++++|+||+|++++..+.++++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~g~-~~~lAa~~i~~~i~~~~~~~~~gi~~a~~~lvg~~~Ga~~~~~~~~~~~~~l~l~~~~ 324 (453)
T PRK09575 246 MYLYGSFVVALHNRLFMEYGS-ALTVGAYAIVGYLMVLYYLVAEGIAEGMQPPVSYYFGARQYDNIKKLLKLAMKVTVLA 324 (453)
T ss_pred HHHHHHHHHHHHHHHHHHhCc-hHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHhcCCChHHHHHHHHHHHHHHHHH
Confidence 999999999998888888885 3457799999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhhhhhhhcccC-cHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHHHHHH
Q 012822 362 SVVFAVIVLALRHVISYAFTS-GEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGIPLGC 440 (456)
Q Consensus 362 ~~~~~~~~~~~~~~i~~l~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l~~ 440 (456)
+++.++++..+++++.++|++ |+|+.+.+..++++..++.++++++.+..+++++.||++.++..++.. +++++|+.+
T Consensus 325 ~~~~~~~~~~~~~~i~~lf~~~~~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~-~~v~ip~~~ 403 (453)
T PRK09575 325 GIAWVLLLNLFPETMIALFNSGDSELIAETIVGIRLHLFAMFLDGFLVLASAYFMAVNQGGKALFISIGN-MLIQLPFLF 403 (453)
T ss_pred HHHHHHHHHHhHHHHHHhHcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcHHHHHHHHHh-HHHHHHHHH
Confidence 999999999999999999985 788999999999999999999999999999999999999999999876 678999999
Q ss_pred HHHhhcCCCcceeec
Q 012822 441 LLGFKFNFGAKVKIR 455 (456)
Q Consensus 441 ~l~~~~~~G~~G~~~ 455 (456)
++... +|+.|+|.
T Consensus 404 ll~~~--~G~~Gvw~ 416 (453)
T PRK09575 404 ILPKW--LGVDGVWL 416 (453)
T ss_pred HHHHH--HCcchHhh
Confidence 99865 49999984
No 5
>PRK01766 multidrug efflux protein; Reviewed
Probab=100.00 E-value=7.1e-47 Score=371.87 Aligned_cols=410 Identities=22% Similarity=0.341 Sum_probs=374.4
Q ss_pred HHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 012822 43 ASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (456)
Q Consensus 43 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~ 122 (456)
..++.+|++++.++|.+++++...+.+.+|+.+++++|++++++++.+.++.. +...+..|++.+..+.++|++|++|+
T Consensus 6 ~~~~~~~~il~~~~P~~~~~~~~~~~~~~d~~~i~~~g~~~laa~~~~~~~~~-~~~~~~~g~~~a~~~~vs~~~g~~~~ 84 (456)
T PRK01766 6 KYKSEARQLLALALPILLAQVAQTAMGFVDTVMAGGVSATDLAAVAIGTSIWL-PVILFGHGLLLALTPIVAQLNGAGRR 84 (456)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhcCCCh
Confidence 34667899999999999999999999999999999999999999999999877 67778899999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHH
Q 012822 123 EMLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA 201 (456)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 201 (456)
|+.++..+.++.+++.++++++++ +.+.++++.+++.|++..+.+..|+++.+++.++..+...+++++++.|+++.++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~yl~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 164 (456)
T PRK01766 85 ERIAHQVRQGLWLALFLSVLIMLVLYNAVPPILNMMNLEPEVADIAVGYLHALLWGIPAYLLYQVLRSFIDGLGKTKPTM 164 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence 999999999999999999888765 6777888899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhh----CCccchhHHHHHHHHHHHHHHHHHHHHhccccc--ccccCCChhhHhhHHHHHHH
Q 012822 202 YISAATLVLHLLLSWLVVYKF----GAGLIGASLVLSLSWYIIVGAQFAYILMSDKCK--HTWTGFSVQAFSGICEFLKL 275 (456)
Q Consensus 202 ~~~~~~~~~~i~l~~~li~~~----~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 275 (456)
+.++++.++|+++++++++.. ++|+.|+++++.+++++..++..++.+++++.+ +.+.++.+..++..|++++.
T Consensus 165 ~~~~i~~ivni~l~~~li~~~~~~~~~Gv~Gaa~at~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~l 244 (456)
T PRK01766 165 VIGFLGLLINIPLNYIFIYGKFGFPELGGVGCGVATAIVYWVMFLAMLIYIKRARRFRDFRLFKGLYKPDWAVIKRLLKL 244 (456)
T ss_pred HHHHHHHHHHHHHHHHHHcCCCCCcccccccHHHHHHHHHHHHHHHHHHHHHhChhhhHHHhhccccCCCHHHHHHHHHc
Confidence 999999999999999998642 479999999999999999999888877653321 11122222334668999999
Q ss_pred HhHHHHHHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHH
Q 012822 276 SGSSAVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVT 355 (456)
Q Consensus 276 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 355 (456)
++|..++...+...+..++.+++++|+. ++++++++.++.++..+++.+++++..+.+++++|+||++++++..+.++
T Consensus 245 ~~P~~~~~~~~~~~~~~~~~~~~~~G~~--~lAa~~i~~~i~~~~~~~~~gl~~a~~~~v~~~~Ga~~~~~~~~~~~~~~ 322 (456)
T PRK01766 245 GLPIGLAIFFEVSLFAVVTLLVSPLGTV--TVAAHQIALNFSSLLFMLPLSLAMALTIRVGFELGAGRTLDARQYAYIGL 322 (456)
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHcChH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCHHHHHHHHHHHH
Confidence 9999999999999999999999999854 46699999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHH
Q 012822 356 SISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVG 435 (456)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~ 435 (456)
+++..++++.+++++.+++++.++|++|+++.+.+..++++..++.++++++....+++++.||+|.++++++.+.|++.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~~~l~g~g~~~~~~~~~~~~~~~~~ 402 (456)
T PRK01766 323 AVGLGMALLTAIFLVLFREQIALLYTDDPEVVALASHLLLFAALFQFSDAIQVIGSGALRGYKDTRVIFFITFIAYWVLG 402 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhchhccCccHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999989999
Q ss_pred HHHHHHHHhhcCCCcceeec
Q 012822 436 IPLGCLLGFKFNFGAKVKIR 455 (456)
Q Consensus 436 i~l~~~l~~~~~~G~~G~~~ 455 (456)
+|+.+++....++|+.|+|.
T Consensus 403 i~~~~~l~~~~~~G~~G~~~ 422 (456)
T PRK01766 403 LPLGYILALTDPMGPFGFWI 422 (456)
T ss_pred HHHHHHHHhccCCCceehHH
Confidence 99999999888899999983
No 6
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=100.00 E-value=2.8e-46 Score=362.94 Aligned_cols=401 Identities=17% Similarity=0.152 Sum_probs=351.4
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcc
Q 012822 45 WLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHL-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYE 123 (456)
Q Consensus 45 ~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~ 123 (456)
.++.|++++.++|.++++++..+++.+|+.+++++ |++++++.+++.++.. +...+..+++.+..+.++|++|++|+|
T Consensus 5 ~~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~l~g~~alAa~~l~~~i~~-~~~~~~~~~~~g~~~lvsq~~Ga~~~~ 83 (441)
T PRK10367 5 TSSDKALWRLALPMIFSNITVPLLGLVDTAVIGHLDSPVYLGGVAVGATATS-FLFMLLLFLRMSTTGLTAQAFGAKNPQ 83 (441)
T ss_pred cccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhCCCCHH
Confidence 34578899999999999999999999999999998 7889999999999999 778888999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHH
Q 012822 124 MLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAY 202 (456)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 202 (456)
++++..++++.+++++++++.++ ..+.++++.+++.|+++.+.+.+|+++..++.|+..+....++++|+.||+|.+++
T Consensus 84 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ll~~~g~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~~~ 163 (441)
T PRK10367 84 ALARALVQPLLLALGAGALIALLRTPLIDLALHIVGGSEAVLEQARRFLEIRWLSAPASLANLVLLGWLLGVQYARAPVI 163 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccchHHHH
Confidence 99999999999999998888755 77888888999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhcccccc-cccCCChhhHhhHHHHHHHHhHHHH
Q 012822 203 ISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKH-TWTGFSVQAFSGICEFLKLSGSSAV 281 (456)
Q Consensus 203 ~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~p~~~ 281 (456)
.++++.++|+++++++++.+++|+.|+++|+.+++++..++..++++++++.+. +.+.++.+.++.+|++++++.|..+
T Consensus 164 ~~ii~~~vni~l~~~lI~~~~lGv~Gaa~At~is~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~ig~P~~~ 243 (441)
T PRK10367 164 LLVVGNILNIVLDLWLVMGLHMNVQGAALATVIAEYATLLIGLLMVRKVLKLRGISLEMLKTAWRGNFRRLLALNRDIML 243 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCccHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHhhhhhHHHHHHHHHhCchHHH
Confidence 999999999999999999888999999999999999998888777765422221 1111221112468999999999999
Q ss_pred HHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHH
Q 012822 282 MLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFII 361 (456)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (456)
+.......+.+.+.+++++|+ .++++|+++.++.++..++..+++++..|.++|++|+||.|++|+..+++.++...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~G~--~alAa~~I~~~i~~~~~~~~~gl~~a~~~lvg~~~Ga~~~~~a~~~~~~~~~~~~~~ 321 (441)
T PRK10367 244 RSLLLQLCFGAITVLGARLGS--DIIAVNAVLMTLLTFTAYALDGFAYAVEAHSGQAYGARDGSQLLDVWRAACRQSGIV 321 (441)
T ss_pred HHHHHHHHHHHHHHHHHhcCH--HHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999985 357799999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccC---cchhHHHHHHHHHHHHHHHH
Q 012822 362 SVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCG---WQAFVAYVNIACYYIVGIPL 438 (456)
Q Consensus 362 ~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g---~~~~~~~~~~~~~~~~~i~l 438 (456)
+.+.+++++.+++++.++|++|+|+.+.+..++++.++..+......+...++++.+ |+|.++.++.++.|+..++.
T Consensus 322 ~~~~~~~~~~~~~~i~~lFt~d~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~g~lrg~dt~~~~~~~~~~~~~~~~~~ 401 (441)
T PRK10367 322 ALLFSLVYALAGEHIIALLTSLPQIQQLADRYLIWQVILPLVGVWCYLLDGMFIGATRAAEMRNSMAVAAAGFALTLLTL 401 (441)
T ss_pred HHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCccchHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999998876443334444444555555 59999999999877533322
Q ss_pred HHHHHhhcCCCcceeec
Q 012822 439 GCLLGFKFNFGAKVKIR 455 (456)
Q Consensus 439 ~~~l~~~~~~G~~G~~~ 455 (456)
+ ++|+.|+|.
T Consensus 402 -----~--~~g~~Gvw~ 411 (441)
T PRK10367 402 -----P--WLGNHGLWL 411 (441)
T ss_pred -----H--HcCchHHHH
Confidence 1 358999884
No 7
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=100.00 E-value=1.1e-36 Score=288.97 Aligned_cols=338 Identities=33% Similarity=0.576 Sum_probs=305.9
Q ss_pred HHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHHHHHHHH
Q 012822 57 PAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQRATFVL 136 (456)
Q Consensus 57 p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~~~~~~~~~~~~~~ 136 (456)
|.++++++..+...+|+.+++++|++++++++++.++.. +...+..|++++..+.++++.|++|+|+.++..+....+.
T Consensus 1 p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~a~~i~~-~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 79 (342)
T TIGR00797 1 PAILANILQPLLGLVDTAFVGHLGPVDLAAVSLGSSVFM-FLFSILMGLGTATTALVAQAVGAGNYQRLGRQAQQSLLLA 79 (342)
T ss_pred ChHHHHHHHHHHHHHHHHHHhcccHHHHHHHHHhHHHHH-HHHHHHHHHHHhHHHHHHHHHCCCChHHHHHHHHHHHHHH
Confidence 788999999999999999999999999999999999888 8888999999999999999999999999999999999999
Q ss_pred HHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHHHHHHHHHHHHHH
Q 012822 137 LATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVLHLLLS 215 (456)
Q Consensus 137 ~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~ 215 (456)
..++++.+++ +.+.+++..+++.|++..+.+..++++..+..++..+.....+.+++.||++.....++++.+++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~i~~~~~~i~~~ 159 (342)
T TIGR00797 80 LLLGLPVLLVGYFFIDPLLSLMGADGEVAELAQDYLRILILGIPAYLLNFVLRGFLRGQGDTKTPMYITLIGNVINIILN 159 (342)
T ss_pred HHHHHHHHHHHHHhHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchHHHHHHHHHHHHHHHHh
Confidence 9999988865 788888888888788888899999999999999999999999999999999999999999999999999
Q ss_pred HHHHH-hhC-CccchhHHHHHHHHHHHHHHHHHHHHhcccccccccCCChhhHhhHHHHHHHHhHHHHHHHHHHHHHHHH
Q 012822 216 WLVVY-KFG-AGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLCLETWYFQIL 293 (456)
Q Consensus 216 ~~li~-~~~-~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 293 (456)
+++++ .++ +|+.|+++++.+++++..++.+++.+|+++.+.++++..+.+++.+|++++++.|..++++..++...++
T Consensus 160 ~~li~~~~g~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~P~~~~~l~~~~~~~~~ 239 (342)
T TIGR00797 160 YILIFGKFGFLGIVGAALATVISYWLMFLLLLYYIKKAKKIGLKWEGLLKPDWEVLKRLLKLGLPIAFRVILESLSFALL 239 (342)
T ss_pred HHHHhcCccccccHHHHHHHHHHHHHHHHHHHHHHHhCCCcccccccccCCCHHHHHHHHHhCchHHHHHHHHHHHHHHH
Confidence 98887 567 7899999999999999999888777764333333222222234669999999999999999999999999
Q ss_pred HHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 012822 294 VLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVVFAVIVLALR 373 (456)
Q Consensus 294 ~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (456)
+.+++.+|+ .++++|+++.++.++...++.+++++..|.++++++++|.++.++..++++++.+.++++.++++.+++
T Consensus 240 ~~i~~~~g~--~~v~~~~~a~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 317 (342)
T TIGR00797 240 ALLVARLGS--IALAAHQIALNVESLLFMPAFGFGIAVSILVGQALGAGDPKRAKEVARVALKLSLLLGLVLAIILILFR 317 (342)
T ss_pred HHHHHHcCc--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999998874 446799999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCcHHHHHHHHhHhHHH
Q 012822 374 HVISYAFTSGEVVANAVSELCPLL 397 (456)
Q Consensus 374 ~~i~~l~~~~~~~~~~~~~~l~~~ 397 (456)
+++.++|++|+++.+.+..++++.
T Consensus 318 ~~i~~~~~~~~~~~~~~~~~~~~~ 341 (342)
T TIGR00797 318 EFIARLFTNDPEVLELAAIYLIFV 341 (342)
T ss_pred HHHHHHhCCCHHHHHHHHHHHHHh
Confidence 999999999999888888887764
No 8
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=100.00 E-value=1.8e-34 Score=288.24 Aligned_cols=392 Identities=13% Similarity=0.088 Sum_probs=325.5
Q ss_pred HHHhhHHHHHHHHHHHHHHHHHHHHhhc-cChhHH-HHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHhhhcCCCcchHHH
Q 012822 51 LVRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLEL-AAASLGNSGIQLFAYGLM-LGMGSAVETLCGQAYGAGRYEMLGV 127 (456)
Q Consensus 51 ~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~-~~~~~~~~i~~~~~~~~~-~g~~~a~~~~vs~~~g~~~~~~~~~ 127 (456)
+.|.+.-..++++++.+.+++|..++++ +|++++ ++++.+.++.+++..... .|++++..+...++.+++ |+.++
T Consensus 2 ~~k~~~i~~~~~~~~~~~~~~~~~~~a~~lG~~~~~~~~~~~~~i~~~~~~~~~~~g~~~a~i~~~~~~~~~~--~~~~~ 79 (502)
T TIGR01695 2 LLKSTLIVSLGTLFSRITGFVRDAIIASAFGAGLTADAFNVAFVIPNFFRRLFAEGAFNSAFVPVFTKAKKKE--KEARR 79 (502)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChHhhHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHhhh--hHHHH
Confidence 5678889999999999999999999999 699999 899999999873433333 578888777776654322 56776
Q ss_pred HHHHHHHHHHHHHH-HHHHH-HHhhHHHHHHc--CCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHH
Q 012822 128 YMQRATFVLLATGV-PVMMV-YIFCKPMLILL--GESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYI 203 (456)
Q Consensus 128 ~~~~~~~~~~~~~~-~~~~~-~~~~~~i~~~~--~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 203 (456)
....+.......+. +..++ +.+.+++..++ +.+++..+.+.+|+++..++.++..+....++++|+.+|++.+.+.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~g~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 159 (502)
T TIGR01695 80 AFANTVTTLLILSLLLVVLIGIFFAPFVISLLAPGFADETRSLAVSLTRIMFPYLLLISLAAVFGGILNARKRFFIPSFS 159 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeeHHHHHH
Confidence 67666665554444 33444 67777777777 4566777889999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhCCccchhH--HHHHHHHHHHHHHHHHHHHhcccccccccCCChhhHhhHHHHHHHHhHHHH
Q 012822 204 SAATLVLHLLLSWLVVYKFGAGLIGAS--LVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAV 281 (456)
Q Consensus 204 ~~~~~~~~i~l~~~li~~~~~g~~g~~--~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 281 (456)
+++..+++++...++ ..++|..|++ +++++++.+..++.+++.+|++ .+. +.+++. +++..|++++++.|..+
T Consensus 160 ~i~~~i~~i~~~~~~--~~~~g~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~-~~~~~~-~~~~~k~~l~~~~p~~~ 234 (502)
T TIGR01695 160 PILFNIGVILSLLFF--DWNYGQYSLALAIGVLIGGVAQLLIQLPFLRKAG-FLL-KPRFNF-RDPGLKRFLKLFLPTTL 234 (502)
T ss_pred HHHHHHHHHHHHHHH--HcccchHHHHHHHHHHHHHHHHHHHHHHHHHHCC-Ccc-cCcCCC-CChhHHHHHHHHHHHHH
Confidence 999988776643333 3368999988 9999999999888877766542 111 112222 23568999999999999
Q ss_pred HHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHH
Q 012822 282 MLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFM-VSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFI 360 (456)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~-i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (456)
++....+...+++.+.+.++++ ++++|+.++++.+++.. +..+++++..|.++++++++|.+++++..+++.+....
T Consensus 235 ~~~~~~~~~~id~~~~~~~~~~--~v~~~~~a~~l~~~~~~~~~~~i~~~~~P~~s~~~~~~~~~~~~~~~~~~~~~~~~ 312 (502)
T TIGR01695 235 GSSASQITLLINTALASFLEIG--SVSALYYANRIYQLPLGIFGISLSTVLLPKLSRHASEGNWNELRDLLNQGIRLSLL 312 (502)
T ss_pred HHHHHHHHHHHHHHHHhcCCcc--hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHH
Confidence 9999999999999887776643 46699999999998765 57899999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhhhhhhhcccC----cHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHH
Q 012822 361 ISVVFAVIVLALRHVISYAFTS----GEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGI 436 (456)
Q Consensus 361 ~~~~~~~~~~~~~~~i~~l~~~----~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i 436 (456)
++++.++++.++++++.++|.+ |++.++.+..++++++++.++.+++.+..+.+++.||+|.+++.+..+ .++++
T Consensus 313 ~~~~~~~~l~~~~~~ii~l~~~~~~f~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~a~g~~~~~~~~~~~~-~~i~i 391 (502)
T TIGR01695 313 LTIPSSFGLLILSIPIVSLLFERGAFSEEDTVMTATILAAYGLGLIFYSLQKVLLRAFYARKDTRTPFINSVIS-VVLNA 391 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhccCCccCHHHHHHH-HHHHH
Confidence 9999999999999999999876 456788899999999999999999999999999999999999999887 67899
Q ss_pred HHHHHHHhhcCCCcceee
Q 012822 437 PLGCLLGFKFNFGAKVKI 454 (456)
Q Consensus 437 ~l~~~l~~~~~~G~~G~~ 454 (456)
++.+++.+. +|..|+|
T Consensus 392 ~l~~~l~~~--~G~~G~~ 407 (502)
T TIGR01695 392 LLSLLLIFP--LGLVGIA 407 (502)
T ss_pred HHHHHHHHH--HhhhHHH
Confidence 999999876 4888876
No 9
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=100.00 E-value=3e-34 Score=285.69 Aligned_cols=394 Identities=13% Similarity=0.129 Sum_probs=326.9
Q ss_pred HHhhHHHHHHHHHHHHHHHHHHHHhhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHH
Q 012822 52 VRLAAPAVFVYLINNLMSLSTRVFCGHL-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQ 130 (456)
Q Consensus 52 ~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~~~~~~~~ 130 (456)
.|.+.|.+++++...+.+.+|+.+++|+ |++++|.++.+.++..++......|++++..+.++++.|++|+++.++.++
T Consensus 2 ~~~~~~~~~~~~~~~~~~~i~~~~l~r~Lg~~~~G~~~~~~~~~~~~~~~~~~Gl~~a~~~~is~~~~~~~~~~~~~~~~ 81 (488)
T TIGR02900 2 LKGTFILTIANLITRILGFIFRIVLSRILGAEGVGLYGMAMPIYFLFITLTTGGLPVAISKFVAEASAKNDRKNIKKILK 81 (488)
T ss_pred hHhHHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhhHHHHHHHHHHHHHHHHhCCcHHHHHHHHHHHHhccchhhHHHHHH
Confidence 4678999999999999999999999995 999999999999998844555567999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHHHHHHHH
Q 012822 131 RATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLV 209 (456)
Q Consensus 131 ~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 209 (456)
.+..+.+..+++++++ +.+.+++...++.+++. ..++++..+..++..+....+..+|+.+|.+.....++++.+
T Consensus 82 ~~~~l~l~~~~~~~~l~~~~~~~i~~~~~~~~~~----~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~i~~i 157 (488)
T TIGR02900 82 VSLIFTLIWSLIVTAIVFLLSPFIASTLLKDERS----LYSLLVICPAMPFIALSSVLKGYFQGISNMKPPAYIQVIEQI 157 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHHHHHHcCChhH----HHHHHHHHHHHHHHHHHHHHHHHHhhhccchHhHHHHHHHHH
Confidence 9999999999888765 66677766666665543 346788888999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhh-----CCccchhHHHHHHHHHHHHHHHHHHHHhccccccc--ccCCChhhHhhHHHHHHHHhHHHHH
Q 012822 210 LHLLLSWLVVYKF-----GAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHT--WTGFSVQAFSGICEFLKLSGSSAVM 282 (456)
Q Consensus 210 ~~i~l~~~li~~~-----~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~p~~~~ 282 (456)
+++.++..++..+ +.|+.|+++++.+++.+..+..+++++|+++.+.+ +.+.....++.+|+++++++|..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~v~g~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~l~~~~~p~~l~ 237 (488)
T TIGR02900 158 VRISVVALLISAFLPYGLEYAVAGAYLSLVLGELVSLLYLYFFFKRKKSFSIRFPFFDYKSEGKALLFDLFSVSLPLTLS 237 (488)
T ss_pred HHHHHHHHHHHHHHhcChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccccccCcchHHHHHHHHHHHHHHHHH
Confidence 9987766655422 35678888999999999988877666554332211 1111122345789999999999999
Q ss_pred HHHHHHHHHHHHHHHhcCC----c-HH---HHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHH
Q 012822 283 LCLETWYFQILVLIAGLLD----N-PE---LALDSL-SVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVV 353 (456)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~----~-~~---~av~~~-~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~ 353 (456)
++...+....|+.++++.. . .. ..++.| +++.++..++..+..+++++..|.++++++++|.++.++..++
T Consensus 238 ~~~~~~~~~~d~~ii~~~l~~~g~~~~~a~~~~g~~~~~a~~i~~~~~~~~~~l~~~~~p~~s~~~~~~~~~~~~~~~~~ 317 (488)
T TIGR02900 238 RFIGSLLYFLETLLVPQRLVIAGVTYREATSLYGKLSGMAMPLLTFPAVITSSLSTALVPDISEAMAKKNYSSIEKRINQ 317 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHChHHHHHHhHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence 9999999999988887542 1 11 223344 4667788888888999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHH
Q 012822 354 VTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYI 433 (456)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~ 433 (456)
.++....+++|.++++..+++++.+++.++++ +..++++++++.++.+++.+..+++++.||+|..++.++.+ .+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~~----~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~-~i 392 (488)
T TIGR02900 318 AIKISLLLGLITTVILLVIPDELGALFYGRPD----AGNFIRVLAPSFPFLYFSAPLQSILQGLGKQKVALRNSLIG-AI 392 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCc----hHHHHHHHHHHHHHHHHHHHHHHHHHhcCcchHHHHHHHHH-HH
Confidence 99999999999999999999999999876443 56789999999999999999999999999999999999998 68
Q ss_pred HHHHHHHHHHhhcCCCcceee
Q 012822 434 VGIPLGCLLGFKFNFGAKVKI 454 (456)
Q Consensus 434 ~~i~l~~~l~~~~~~G~~G~~ 454 (456)
+++++.+++.....+|+.|.|
T Consensus 393 ~~i~l~~~l~~~~~~G~~Gaa 413 (488)
T TIGR02900 393 VKIILLFVLTSIPSINIYGYA 413 (488)
T ss_pred HHHHHHHHHHhccccccHHHH
Confidence 889998888733346888876
No 10
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Probab=100.00 E-value=2.1e-34 Score=277.23 Aligned_cols=409 Identities=46% Similarity=0.782 Sum_probs=392.3
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcch
Q 012822 45 WLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEM 124 (456)
Q Consensus 45 ~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~~ 124 (456)
..+.|++++++.|+++..+.......+++.++||+|+.++++.+++.+..+.....+..|+..+..++++|++|.++++.
T Consensus 24 ~~e~k~l~~ia~P~i~~~~~~~~~~~is~~f~GhlG~leLaa~sla~s~~n~~~~s~~~gl~~aletlcgQa~ga~~~~~ 103 (473)
T KOG1347|consen 24 VTESKELARLALPAILTFLAQPLLSLVSTAFAGHLGNLELASVSLANSFANITGVSILLGLQLALDTLCGQAFGAKKFTA 103 (473)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhHHhhhccccchHHHHHHHHHHhhcccchHHhhccchhhhcchHhhhcccccch
Confidence 67889999999999999999999999999999999999999999999999966788999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHHH
Q 012822 125 LGVYMQRATFVLLATGVPVMMVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYIS 204 (456)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 204 (456)
...+.+++........++..+++.+.+++...++.|+++...+..|.+...+..+..........++|++++.....+..
T Consensus 104 lg~~lqrs~~~l~~~~~~~~~l~~~~~~il~~lgq~~~i~~~a~~y~~~~ip~~~a~~~~~~l~~~lq~Q~~~~~~~~~~ 183 (473)
T KOG1347|consen 104 LGVYLQRSGIVLLVQGLPISLLILNSEPILLLLGQDPDISRDAGSYAFMLIPGLFSYAVSFPLAKFLQAQSITLPLLVIG 183 (473)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHccHHHHHHhCCChhHHHHHhhhHhhhcchhhhhHHHHHHHHHHHhccCchHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhcccccccccCCChhhHhhHHHHHHHHhHHHHHHH
Q 012822 205 AATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLC 284 (456)
Q Consensus 205 ~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 284 (456)
....++++.+++++++..++|..|++++..+++++.......|..... ....|..++.+ ++.++++++.+.|..++..
T Consensus 184 ~~~~~lhi~~~~llv~~~~~g~~Gaala~~~s~w~~~~~l~~yi~~~~-~~~~w~~~s~~-~~~~~~~~~lai~s~~mic 261 (473)
T KOG1347|consen 184 LVALVLHILLTWLLVSKLGLGIKGAALALVASYWLNVRILLLYAVLSG-CLAAWSGFSGE-FDSWGPFFALAIPSAVMIC 261 (473)
T ss_pred HHHHHHHHHHHHHhhhcccCCCccchHHHHHHHHHHHHHHHHHheecC-chhhhhhhhHh-hhhHHHHHHHhhcchheeH
Confidence 999999999999999999999999999999999999999988887663 55667777777 7889999999999999999
Q ss_pred HHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHH
Q 012822 285 LETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVV 364 (456)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (456)
++++.+....++.+.++.++.++++.++..++....++++.+++.+...++++.+|+++++.+|...+.....++.++..
T Consensus 262 lE~w~~eil~l~~G~l~np~~~~~~~sI~~~~~~~~~~~~~~~~~a~strv~neLGag~p~~ar~~~~v~~~~~~~~g~~ 341 (473)
T KOG1347|consen 262 LEWWAYEILVLLAGLLGNAKVSLASQSICLEIGGWHLMIPGAFSAAVSTRVSNELGAGKPKRARVSAKVALQTSVAIGAS 341 (473)
T ss_pred HHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHcCCChhhhhhHHHHHHHHHHHHHHH
Confidence 99999999999999999878889999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHHHHHHHHHh
Q 012822 365 FAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGIPLGCLLGF 444 (456)
Q Consensus 365 ~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l~~~l~~ 444 (456)
.+..+....+.+..+|++|+++.+...+..++++...++++.+.+..+..++.|+++...++++.++.+.++|..+.+..
T Consensus 342 ~~~~~~~~r~~~~~ift~~~ev~~~va~~~pll~~~~~~~~~q~v~~Gva~g~g~q~~ga~vnl~~yyl~G~p~g~~l~~ 421 (473)
T KOG1347|consen 342 LGTTLLACREVLGQIFTNSKEVLDLVADLTPLLALSILLNALQAVLSGVARGSGWQQIGAVINLVAYYLVGAPVGLYLGF 421 (473)
T ss_pred HHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHhccchhhhhheEEeeccccceEEEeeeeeeEecCcceeEEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred hcCCCcceeec
Q 012822 445 KFNFGAKVKIR 455 (456)
Q Consensus 445 ~~~~G~~G~~~ 455 (456)
..++|..|+|.
T Consensus 422 ~~~~g~~glw~ 432 (473)
T KOG1347|consen 422 FTKFGVKGLWI 432 (473)
T ss_pred EEecCceEEEe
Confidence 88999999995
No 11
>PRK15099 O-antigen translocase; Provisional
Probab=100.00 E-value=4.3e-32 Score=263.86 Aligned_cols=385 Identities=12% Similarity=0.025 Sum_probs=321.6
Q ss_pred HHHhhHHHHHHHHHHHHHHHHHHHHhhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHH
Q 012822 51 LVRLAAPAVFVYLINNLMSLSTRVFCGHL-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYM 129 (456)
Q Consensus 51 ~~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~~~~~~~ 129 (456)
+.|.+.+...+++...+.+++...+++|+ |++++|.++...++...+......|++++..+.++|+ ++|+|+.++..
T Consensus 3 ~~k~~~~~~~~~~~~~~~~~l~~~i~ar~Lg~~~~G~~~~~~~~i~~~~~~~~~G~~~a~~~~ia~~--~~~~~~~~~~~ 80 (416)
T PRK15099 3 LAKASLWTAASTLVKIGAGLLVVKLLAVSFGPAGVGQAGNFRQLITVLGVLAGAGIFNGVTKYVAQY--HDQPQQLRAVV 80 (416)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCcHHHHHHHHHHHHHHHHHHHHcCCccceeeeeHHhc--CCCHHHHHHHH
Confidence 56788899999999999999999999995 9999999999999988555556889999988999987 67888999999
Q ss_pred HHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHHHHHHH
Q 012822 130 QRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATL 208 (456)
Q Consensus 130 ~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 208 (456)
+.++.+.+..+++++++ +.+.+++...++.+++. ..+..+..+..++..+.....+.+|+.||++.+....+++.
T Consensus 81 ~~~~~l~~~~~~i~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~lr~~~~~~~~~~~~~~~~ 156 (416)
T PRK15099 81 GTSSAMVLGFSTLLALVFLLAAAPISQGLFGHTDY----QGVVRAVALIQMGIAWANLLLAILKGFRDAAGNALSLIVGS 156 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChhH----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999888855 78888888877766653 23466666666677888899999999999999999999999
Q ss_pred HHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhcccccccccCCChhhHhhHHHHHHHHhHHHHHHHHHHH
Q 012822 209 VLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLCLETW 288 (456)
Q Consensus 209 ~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 288 (456)
++|+.+ .++...+ .|+.|+++|+++++.+..+...++++|+++.+.++.+++.+ ++.+|+++++|.|..+++....+
T Consensus 157 ~~~i~l-~i~~~~~-~Gv~Ga~iat~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~k~ll~~g~p~~~~~~~~~i 233 (416)
T PRK15099 157 LIGVAA-YYLCYRL-GGYEGALLGLALVPALVVLPAGIMLIRRGTIPLSYLKPSWD-NGLAGQLGKFTLMALITSVTLPV 233 (416)
T ss_pred HHHHHH-HHHHHHH-hcchHHHHHHHHHHHHHHHHHHHHHHHccceehHhhhccCC-HHHHHHHHHHHHHHHHHHHHHHH
Confidence 999877 4444332 49999999999999998887777776553322221122222 35689999999999999999999
Q ss_pred HHHHHHHHHh-cCCcHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHH
Q 012822 289 YFQILVLIAG-LLDNPELALDSLSVCMAVSGL-LFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVVFA 366 (456)
Q Consensus 289 ~~~~~~~~~~-~~~~~~~av~~~~~~~~i~~~-~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (456)
....++.+++ .+|+ .++|.|+.+.|+.+. ...+..+++++..|.+++. +|.++.++..++..+....++++.+
T Consensus 234 ~~~~~~~~l~~~~g~--~~vg~y~~a~~i~~~~~~~~~~~~~~a~~P~~s~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (416)
T PRK15099 234 AYVMMRNLLAAHYSW--DEVGIWQGVSSISDAYLQFITASFSVYLLPTLSRL---TEKRDITREIVKALKFVLPAVAAAS 308 (416)
T ss_pred HHHHHHHHHHhcCCH--HHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CChHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999998886 7664 468899999999884 5788999999999999984 6788999999999999999999999
Q ss_pred HHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHHHHHHHHHhhc
Q 012822 367 VIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGIPLGCLLGFKF 446 (456)
Q Consensus 367 ~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l~~~l~~~~ 446 (456)
+++.++++++++++.+|+ ++.+.+++++++++.++...+...+....+.++++......+.. .++++|+.+++.+.+
T Consensus 309 ~~~~l~a~~ii~l~~g~~--~~~~~~~~~~l~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~-~~l~i~l~~~li~~~ 385 (416)
T PRK15099 309 FTVWLLRDFAIWLLFSNK--FTAMRDLFAWQLVGDVLKVGAYVFGYLVIAKASLRFYILAEVSQ-FTLLTGFAHWLIPLH 385 (416)
T ss_pred HHHHHHHHHHHHHhccHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHh
Confidence 999999999999998876 66688899999999999988888888888888888877766665 888999999999875
Q ss_pred CCCcceee
Q 012822 447 NFGAKVKI 454 (456)
Q Consensus 447 ~~G~~G~~ 454 (456)
|..|++
T Consensus 386 --G~~G~a 391 (416)
T PRK15099 386 --GALGAA 391 (416)
T ss_pred --hhHHHH
Confidence 787764
No 12
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=99.98 E-value=1.9e-27 Score=231.46 Aligned_cols=364 Identities=16% Similarity=0.129 Sum_probs=311.6
Q ss_pred cChh-HHHHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHhhhcCCCcchHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHH
Q 012822 79 LGNL-ELAAASLGNSGIQLFAYGLM-LGMGSAVETLCGQAYGAGRYEMLGVYMQRATFVLLATGVPVMMV-YIFCKPMLI 155 (456)
Q Consensus 79 ~g~~-~~~~~~~~~~i~~~~~~~~~-~g~~~a~~~~vs~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~ 155 (456)
+|.+ +..+|.++.++.+++...+. .+++++..|..++.. ++|+|+.++..+....+.....+.++++ ++++++++.
T Consensus 5 fG~s~~~Daf~~A~~ip~~l~~l~~~gal~~~~IP~~~~~~-~~~~~~~~~f~~~~~~~~~~~~~~l~~l~~lfa~~iv~ 83 (451)
T PF03023_consen 5 FGASAEADAFFVAFTIPNFLRSLLAGGALSAAFIPVFSKAR-EKGEEEARRFISTLLTILLIISLLLTLLGILFAPPIVR 83 (451)
T ss_pred hcCCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4544 46689999999994444454 568999999999998 7888999999998888888888877755 888888888
Q ss_pred Hc--CCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHHHHHHHHHHHHHHHHHHHhhCCc---cchhH
Q 012822 156 LL--GESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVLHLLLSWLVVYKFGAG---LIGAS 230 (456)
Q Consensus 156 ~~--~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~li~~~~~g---~~g~~ 230 (456)
.+ +.|++..+.+...+++..+..++..+..++.+++|+++|...+....++.++..++..+++... .| +.+.+
T Consensus 84 ~la~g~~~~~~~la~~l~~i~~~~~~~~~l~~i~~a~L~~~~~F~~~~~~~l~~N~~~I~~~~~~~~~--~~~~~i~~la 161 (451)
T PF03023_consen 84 LLAPGFSPETIELAVQLLRILAPSILFIGLSSIFSAILNAHRRFLIPALSPLLFNLSIILSLLLLSNS--WGQENIYALA 161 (451)
T ss_pred HHCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCcchHHHHHHHHHHHHHHHHHHHHHHh--cCchHHHHHH
Confidence 77 5578888999999999999999999999999999999999999999988887765544433333 56 88999
Q ss_pred HHHHHHHHHHHHHHHHHHHhcccccccccCCChhhHhhHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhcCCcHHHHHHHH
Q 012822 231 LVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLCLETWYFQILVLIAGLLDNPELALDSL 310 (456)
Q Consensus 231 ~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~av~~~ 310 (456)
+|.+++.++..++.+...+|.. .+.+ .+++++ .+..|++++...|..+......+...+++.+.+.++++. ++++
T Consensus 162 ~g~~~g~~~~~l~~l~~~~~~~-~~~~-~~~~~~-~~~~~~~~~~~~p~~l~~~~~qi~~lv~~~laS~l~~G~--vs~l 236 (451)
T PF03023_consen 162 WGVLIGAIIQFLIQLPYLRRFG-FRFR-PKFDWR-DPNLKRFLKLAIPLLLSSSISQINILVDRALASFLGEGS--VSAL 236 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC-Cccc-ccCCCC-ChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCccH--HHHH
Confidence 9999999999999888877652 2211 112222 245899999999999999999999999999999988765 4599
Q ss_pred HHHHHHHHHHHHH-HHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhcccC----cHH
Q 012822 311 SVCMAVSGLLFMV-SVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTS----GEV 385 (456)
Q Consensus 311 ~~~~~i~~~~~~i-~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~----~~~ 385 (456)
+.++++.+++..+ ..+++++..|.+++...++|.++.++..+++++....+.+|+++++..+++++++++.. |.+
T Consensus 237 ~YA~~l~~lp~~i~~~~i~tv~~P~ls~~~~~~d~~~~~~~~~~~l~~~~~i~iP~~~~~~~~a~~iV~llf~rG~F~~~ 316 (451)
T PF03023_consen 237 NYAQRLYQLPLGIFAVSISTVVFPKLSRLAAEGDWEEFRKTLRKALRLILLILIPASIGLIVLAEPIVRLLFERGAFTAE 316 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHccCCCCHH
Confidence 9999999998854 77999999999999999999999999999999999999999999999999999999752 566
Q ss_pred HHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHHHHHHHHHhhcCCCccee
Q 012822 386 VANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGIPLGCLLGFKFNFGAKVK 453 (456)
Q Consensus 386 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l~~~l~~~~~~G~~G~ 453 (456)
..+....++++++++.++.+++......+++.||+|.+++.++.+ .++++.+++++.+.+ |..|+
T Consensus 317 ~~~~ta~~l~~y~~~l~~~~l~~ll~r~fya~~~~~~~~~~~~~~-~~lni~l~~~l~~~~--g~~Gl 381 (451)
T PF03023_consen 317 DTQLTASALRIYALGLPFYALNDLLSRVFYALGDTKTPVRISVIS-VVLNIILSILLVPFF--GVAGL 381 (451)
T ss_pred HHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHccCcHhHHHHHHHH-HHHHHHHHHHHHHHH--HHHHH
Confidence 688899999999999999999999999999999999999999988 889999998888875 77775
No 13
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=99.97 E-value=2.4e-26 Score=219.63 Aligned_cols=392 Identities=15% Similarity=0.082 Sum_probs=327.4
Q ss_pred HHHHHhhHHHHHHHHHHHHHHHHHHHHhhc-cChh-HHHHHHHHHHHHHHHHHH-HHHHHHHhHHHHHHhhhcCCCcchH
Q 012822 49 KLLVRLAAPAVFVYLINNLMSLSTRVFCGH-LGNL-ELAAASLGNSGIQLFAYG-LMLGMGSAVETLCGQAYGAGRYEML 125 (456)
Q Consensus 49 ~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~-~~~~~~~~~~i~~~~~~~-~~~g~~~a~~~~vs~~~g~~~~~~~ 125 (456)
++++|.+.-....++++.+.+++...+++. +|++ ...++.++.++.+++--. ....++++..|...++..++++|+.
T Consensus 7 ~sllks~~~vs~~Tl~SRi~G~vRd~~iA~~fGa~~~aDAF~vAf~iPN~lRrlfaegafs~aFVPv~~~~~~~~~~~~~ 86 (518)
T COG0728 7 MSLLKSLIIVSSATLLSRILGFVRDVLIAAAFGAGAAADAFFVAFKLPNLLRRLFAEGAFSSAFVPVLAEAKKKEGEEAA 86 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCchHHHHHHHHHHhHHHHHHHHhchhHhhhhhHHHHHHHHcchhhHH
Confidence 457777888888899999999998888888 5874 567999999999944433 4446799999999999888878888
Q ss_pred HHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHc-CC--CHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHH
Q 012822 126 GVYMQRATFVLLATGVPVMMV-YIFCKPMLILL-GE--STAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA 201 (456)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~-~~--~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 201 (456)
++..+........+.+.++++ .++++.++... +. |++....+....++..+..++.++.....+++++.+|...+.
T Consensus 87 ~~f~~~v~~~l~~~ll~vt~L~~l~~p~iv~~~~~~g~~~~~~~~a~~l~~i~~Pyl~~isL~al~~aiLNs~~~F~~~a 166 (518)
T COG0728 87 RFFSRLVTGLLTLVLLLVTLLGILFAPWLVRLLLAPGFDETDKFLAVLLTRILFPYLLFISLSALFGAILNSRNRFFIPA 166 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeechhh
Confidence 887777775666666666655 67777777444 22 233333688888999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhcccccccccCCChhhHhhHHHHHHHHhHHHH
Q 012822 202 YISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAV 281 (456)
Q Consensus 202 ~~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 281 (456)
...+..++.-+...+.+.+.......+.+++..++.+.+.++.+..++|..-..+.. +.+++ +..|++.+...|..+
T Consensus 167 ~aPvl~Nv~~I~~~l~~~~~~~~~~~~La~gvl~Gg~~Q~l~~lp~l~~~g~~~~p~--~~~~~-~~lk~~~~~~~p~~l 243 (518)
T COG0728 167 FAPVLLNVSVIGLALFLGPYFDPPLLALAWGVLIGGLLQLLVQLPALRKAGLLIKPR--FGFKD-PGLKRFLKLMLPALL 243 (518)
T ss_pred hhHHHHHHHHHHHHHHhccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHcccccCCC--CCCCc-hhHHHHHHHHHHHHH
Confidence 999999888776666555553224778899999999999999999998763222211 22221 458999999999999
Q ss_pred HHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHH
Q 012822 282 MLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLF-MVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFI 360 (456)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~-~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (456)
.....+++..+++.+.+.+.++..+ .++.++++.+++. .+..+++++..|.+|++.+++|.++.++..+++++.+++
T Consensus 244 ~~sisQi~lli~~~iAS~l~~Gsis--~l~YA~rl~qlPlGifgvai~tvllP~lSr~~~~~~~~~~~~~l~~~i~l~ll 321 (518)
T COG0728 244 GVSISQINLLIDTAIASFLAEGSVS--WLYYADRLYQLPLGIFGVALSTVLLPSLSRHAANGDWPEFLKLLDWGLRLTLL 321 (518)
T ss_pred HHHHHHHHHHHHHHHHHhhccccHH--HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHhhcCChHHHHHHHHHHHHHHHH
Confidence 9999999999999999999766554 9999999999999 569999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhhhhhhhcccC----cHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHH
Q 012822 361 ISVVFAVIVLALRHVISYAFTS----GEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGI 436 (456)
Q Consensus 361 ~~~~~~~~~~~~~~~i~~l~~~----~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i 436 (456)
.++|.++++.++++|+++++.. ++++.....+.+..++++.++.++..+....+++.+|+|.++++++++ .++++
T Consensus 322 l~lP~~~~l~~la~piv~~Lf~rG~F~~~d~~~ta~~L~~y~~gL~~~~L~~ll~~~FYAr~d~ktP~~i~ii~-~~~n~ 400 (518)
T COG0728 322 LTLPASAGLLVLAEPIVSLLFERGAFTAEDVLMTAEALAAYSLGLIPFALVKLLSRVFYAREDTKTPMKIAIIS-LVVNI 400 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHhccCCCChHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHccCCCcChHHHHHH-HHHHH
Confidence 9999999999999999999743 355678889999999999999999999999999999999999999998 88888
Q ss_pred HHHHHHHhhc
Q 012822 437 PLGCLLGFKF 446 (456)
Q Consensus 437 ~l~~~l~~~~ 446 (456)
.+++.+...+
T Consensus 401 ~l~~~l~~~~ 410 (518)
T COG0728 401 LLNLLLIPPL 410 (518)
T ss_pred HHHHHHHhhc
Confidence 8887777665
No 14
>PRK10459 colanic acid exporter; Provisional
Probab=99.96 E-value=1.5e-25 Score=223.02 Aligned_cols=376 Identities=12% Similarity=0.064 Sum_probs=297.6
Q ss_pred HHHHHhhHHHHHHHHHHHHHHHHHHHHhhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHH
Q 012822 49 KLLVRLAAPAVFVYLINNLMSLSTRVFCGHL-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGV 127 (456)
Q Consensus 49 ~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~~~~~ 127 (456)
++..+.+.+..+++......+++...+++|+ ||+++|.++.+..+..++......|++++.. +. +|.+ ++
T Consensus 5 ~~~~~g~~w~~~~~~~~~~~~~i~~~ilaR~L~p~~~G~~~~~~~~~~~~~~~~~~Gl~~aii----~~---~~~~--~~ 75 (492)
T PRK10459 5 EKTISGAKWTAISTVIIIGLQLVQLTVLARILDNHQFGLLTMSLVIIGFADTLSDMGIGASII----QR---QDIS--HL 75 (492)
T ss_pred HHHHccccHHHHHHHHHHHHHHHHHHHHHHhCCHHHccHHHHHHHHHHHHHHHHHcCHHHHHH----hc---ccCC--HH
Confidence 5677889999999999999999999999995 9999999999999999667777888888752 21 1211 23
Q ss_pred HHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHHHHH
Q 012822 128 YMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAA 206 (456)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 206 (456)
.......+....++++.++ +.+.+++...++ +++. ...+++..+..++..+.......++..++.+.....+..
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~r~~~f~~~a~~~~~ 150 (492)
T PRK10459 76 QLSTLYWLNVGLGIVVFVLVFLLSPLIADFYH-NPEL----APLIKTLSLAFVIIPIGQQFRALLQKELEFNKLAKIEIS 150 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC-Chhh----HHHHHHHHHHHHHHHHhhHHHHHHHHHhhhHHHHHHHHH
Confidence 3445556666666666655 444454444444 4332 345777778888888888899999999999999998888
Q ss_pred HHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhcccccccccCCChhhHhhHHHHHHHHhHHHHHHHHH
Q 012822 207 TLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLCLE 286 (456)
Q Consensus 207 ~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 286 (456)
..+...++...+... ++|+.+.+++..+++.+..+..+...+++ .+++ .+++ ++..|++++++.|...++...
T Consensus 151 ~~i~~~~~~i~~~~~-~~g~~~l~~~~~~~~~~~~l~~~~~~~~~--~~~~-~~~~---~~~~k~ll~~~~~~~~~~~~~ 223 (492)
T PRK10459 151 AVVAGFTFAVVSAFF-WPGALAAILGYLVNSSVRTLLFGYFGRKI--YRPA-LHFS---LASVKPNLSFGAWQTAERIIN 223 (492)
T ss_pred HHHHHHHHHHHHHHH-CCcHHHHHHHHHHHHHHHHHHHHHHhccc--CCcc-ceec---HHHHHHHHhhhHHHHHHHHHH
Confidence 888777776665544 68999999999999888776554333222 1211 1122 345899999999999999999
Q ss_pred HHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHH
Q 012822 287 TWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFM-VSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVVF 365 (456)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~-i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (456)
.+..+.|+++++.+.. +.++|.|+.++++.+.+.. +...++++..|.+++. ++|.++.++.+++..++...+++|+
T Consensus 224 ~~~~~~d~~~lg~~lg-~~~vG~Y~~A~~l~~~~~~~i~~~i~~v~~P~~s~~--~~~~~~~~~~~~~~~~~~~~~~~p~ 300 (492)
T PRK10459 224 YLNTNIDTILIGRILG-AEVLGGYNLAYNVATVPPMKINPIITRVAFPVFAKI--QDDTEKLRVGFLKLLSVLGIINFPL 300 (492)
T ss_pred HHHhcCchhhhhHhhc-hHhhhhHHHHHHHHHHHHHHHHHHHHHHHhHHHHHh--cCCHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999988754 4458899999999987655 4566888999999885 5788999999999999999999999
Q ss_pred HHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHHHHHHHHHhh
Q 012822 366 AVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGIPLGCLLGFK 445 (456)
Q Consensus 366 ~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l~~~l~~~ 445 (456)
++++.+++++++.++.+|+ +..+...++++++..++..+.......+++.||+|..++.+++. .++.+|..+.+.+.
T Consensus 301 ~~~l~~~a~~ii~ll~g~~--~~~a~~~l~il~~~~~~~~~~~~~~~~l~a~g~~~~~~~~~~~~-~~~~i~~~~~~~~~ 377 (492)
T PRK10459 301 LLGLMVVSNNFVPLVFGEK--WNSAIPILQLLCIVGLLRSVGNPIGSLLLAKGRADLSFKWNVFK-TFLFIPAIVIGGQL 377 (492)
T ss_pred HHHHHHHhHHHHHHhcChh--HHhHHHHHHHHHHHHHHHHHHHHHHHHHHHcCccchhHHHHHHH-HHHHHHHHHHHHhh
Confidence 9999999999999988765 78889999999999999999999999999999999999998887 77778877777655
Q ss_pred cCCCccee
Q 012822 446 FNFGAKVK 453 (456)
Q Consensus 446 ~~~G~~G~ 453 (456)
+|+.|.
T Consensus 378 --~G~~g~ 383 (492)
T PRK10459 378 --AGLIGV 383 (492)
T ss_pred --ccHHHH
Confidence 367664
No 15
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=99.95 E-value=5.4e-24 Score=211.35 Aligned_cols=381 Identities=17% Similarity=0.166 Sum_probs=298.6
Q ss_pred HHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchH
Q 012822 47 ELKLLVRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEML 125 (456)
Q Consensus 47 ~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~~~ 125 (456)
..++..|.+.....+++...+.+++....++| +|++++|.++.+.++..++......|++.+....++++.++++++..
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lar~lg~~~~G~~~~~~~~~~~~~~i~~~G~~~ai~r~ia~~~~~~~~~~~ 83 (480)
T COG2244 4 LKKKLIKGALWLLLGTLISALLGLITIPLLARLLGPEGFGLYALALAIIGLFSILADFGLPAAITREIAEYREKGEYLLL 83 (480)
T ss_pred HHHHHHhhchHHHHHHHHHHHHHHHHHHHHHHHhCcccceeeehHHHHHHHHHHHHHcCCcHHHHHHHHHhhcccHHHHH
Confidence 45678889999999999999999999999999 49999999999999999777777899999999999998765554444
Q ss_pred HHH-HHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHHH
Q 012822 126 GVY-MQRATFVLLATGVPVMMVYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYIS 204 (456)
Q Consensus 126 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 204 (456)
... ...........+.+.........+. + +.....++...+..+.........+.+|+.++.+......
T Consensus 84 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~------~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (480)
T COG2244 84 ILLSVLLLLLLALILLLLLLLIAYLLAPI------D----PVLALLLRILSLALLLLPLSSVLRGLFQGFGRFGPLALSI 153 (480)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhccc------C----hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcccchhHH
Confidence 444 4344333333333333222222211 1 2234457788889999999999999999999999999984
Q ss_pred HHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhcccccccccCCChhhHhhHHHHHHHHhHHHHHHH
Q 012822 205 AATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLC 284 (456)
Q Consensus 205 ~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 284 (456)
+.+ ..-+.....+.. .......++..++..........+..+.++. ..+..++. .++..|+++++++|....+.
T Consensus 154 ~~~-~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~l~~~~p~~~~~~ 227 (480)
T COG2244 154 VSS-IFLLAAVFALLF---AALGLAVWALVLGAVVSLLVLLILLGKKKRG-LKRPILRF-SLALLKELLRFGLPLLLSSL 227 (480)
T ss_pred HHH-HHHHHHHHHHHH---HhhhHHHHHHHHHHHHHHHHHHHHHHHhhhh-ccccccCc-hhHHHHHHHHHhhHHHHHHH
Confidence 444 121222222221 2455556666667666666665555422111 11111221 24669999999999999999
Q ss_pred HHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHH
Q 012822 285 LETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVV 364 (456)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (456)
...+..+.|+++++.+.. +..+|.|+.++++......+..+++++..|.+++..+++|.++.++..++..++...+++|
T Consensus 228 ~~~l~~~~D~~~i~~~l~-~~~vG~Y~~a~~i~~~~~~~~~~l~~~l~P~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~p 306 (480)
T COG2244 228 LNFLFTNIDTLLLGLFLG-PAQVGIYSAAQRLVSLLLIVASALNRVLFPALSRAYAEGDRKALKKLLRQSLKLLLLISIP 306 (480)
T ss_pred HHHHHHHHHHHHHHHHhh-hhHheecccccHHHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999998864 4557899999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHHHHHHHHHh
Q 012822 365 FAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGIPLGCLLGF 444 (456)
Q Consensus 365 ~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l~~~l~~ 444 (456)
..+++..+++++..++.+++ +..+...+++++++.++..........+++.|+++..++.+.++ .+.++.+.+++.+
T Consensus 307 ~~~~l~~~~~~~i~~~fg~~--~~~~~~~l~il~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~-~i~~~~l~~~li~ 383 (480)
T COG2244 307 ALLGLLLLAPPIITLLFGEK--YASAAPILQLLALAGLFLSLVSLTSSLLQALGKQRLLLLISLIS-ALLNLILNLLLIP 383 (480)
T ss_pred HHHHHHHHHhhhheeecCCc--ccchhHHHHHHHHHHHHHHHHHHHHHHHHHcCcchhhHHHHHHH-HHHHHHHHhHHHH
Confidence 99999999999999988776 55588899999999999999999999999999999999999988 6788888888887
Q ss_pred hcC
Q 012822 445 KFN 447 (456)
Q Consensus 445 ~~~ 447 (456)
.++
T Consensus 384 ~~g 386 (480)
T COG2244 384 RFG 386 (480)
T ss_pred hhh
Confidence 753
No 16
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=99.90 E-value=2.1e-21 Score=190.73 Aligned_cols=208 Identities=18% Similarity=0.133 Sum_probs=191.8
Q ss_pred HHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCC
Q 012822 42 IASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGR 121 (456)
Q Consensus 42 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~ 121 (456)
+.+++..|++++.++|.+++++.......+|+.+++++|++++++++++.++.. +...+..|++++..++++|++|++|
T Consensus 229 ~~~~~~~k~il~lg~P~~~~~~~~~~~~~i~~~~i~~~G~~alAa~~i~~~i~~-l~~~~~~gi~~a~~~lvgq~~Ga~~ 307 (464)
T PRK00187 229 RPSRAALRELWRLGLPIGGTYAVEVGLFTFAALCMGALGSTQLAAHQIALQIVS-VAFMVPVGLSYAVTMRVGQHYGAGR 307 (464)
T ss_pred CCCHHHHHHHHHhhhhHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 345677999999999999999999999999999999999999999999999999 8899999999999999999999999
Q ss_pred cchHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCC--CH---HHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcC
Q 012822 122 YEMLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGE--ST---AVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQS 195 (456)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~--~~---~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~ 195 (456)
+|++++..+.++.++...+++.+++ +.+.+++..++.+ ++ ++.+.+..|+++.+++.++..++.+..+.+|+.|
T Consensus 308 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~f~~~i~~~ft~~~~~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~~~lrg~G 387 (464)
T PRK00187 308 LLEARRAGRVGIGFGAVVMLLFAGLFWLLPEAIIGLFLDRNDPAFAEIVQLAVSLLAVAAWFELFDGTQTIAMGAIRGLK 387 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCCCccHHHHHHHHHHHHHHHHHHHhhHHHHHHHHhHhccC
Confidence 9999999999999999999888755 7888899988853 33 6888999999999999999999999999999999
Q ss_pred CchhHHHHHHHHH-HHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHh
Q 012822 196 IVLPSAYISAATL-VLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILM 250 (456)
Q Consensus 196 ~~~~~~~~~~~~~-~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~ 250 (456)
+++.++..+++.. ++++++++++.+.+++|+.|+++++.+++++..++....+++
T Consensus 388 ~~~~~~~~~~~~~~~~~ipl~~ll~~~~~~g~~Gvw~~~~i~~~~~~~~~~~~~~~ 443 (464)
T PRK00187 388 DARTTFLIGLACYWLVGAPLAWLLAFTLGWGAVGVWWGLALGLACAAVALTLAFEW 443 (464)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHHhccCCCceeeHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999985 999999999998878999999999999999998877666644
No 17
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=99.88 E-value=1.7e-20 Score=182.74 Aligned_cols=210 Identities=22% Similarity=0.250 Sum_probs=197.6
Q ss_pred hhHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcC
Q 012822 40 LQIASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGA 119 (456)
Q Consensus 40 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~ 119 (456)
..+.+++..|++++.++|..++++.........+.+++++|++.+|+++++.++.+ +...+..|++++.++++++++|+
T Consensus 232 ~~~~~~~~~~~i~~lG~p~~~~~~~~~~~~~~~~~~~~~~G~~~lAa~~i~~~i~~-~~~~~~~gi~~a~~~lvG~~~Ga 310 (455)
T COG0534 232 LLKPDRKLLKEILRLGLPIFLESLSESLGFLLLTLFVARLGTVALAAYGIALRIAS-FIFMPPFGIAQAVTILVGQNLGA 310 (455)
T ss_pred ccCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHHHHHHhcChHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhCC
Confidence 34567789999999999999999999999999999999999999999999999999 99999999999999999999999
Q ss_pred CCcchHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCch
Q 012822 120 GRYEMLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVL 198 (456)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~ 198 (456)
+|.|++++..+.+..+++.+++..+++ +.+.+++..+|.+|+++.+.+..++++..+..++...+....+.+||.||+|
T Consensus 311 ~~~~~a~~~~~~~~~~~~~~~~~~~~i~~~f~~~i~~lF~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~g~lrg~g~~~ 390 (455)
T COG0534 311 GNYKRARRAARLALKLSLLIALLIALLLLLFREPIISLFTTDPEVIALAVILLLIAALFQPFDGIQFVLSGVLRGAGDAK 390 (455)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcH
Confidence 999999999999999999999888855 8899999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHH-HHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 012822 199 PSAYISAAT-LVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (456)
Q Consensus 199 ~~~~~~~~~-~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (456)
.+...++++ ..+.+++.+++.+.. +|..|+|++...++.+..+...+++++.
T Consensus 391 ~~~~~~~~~~~~~~lp~~~~l~~~~-~g~~Gvw~~~~~~~~~~~~~~~~~~~~~ 443 (455)
T COG0534 391 IPFIISLLSYWGFRLPLAYLLGFFF-LGLAGVWIGFPLSLILRAILLLLRLRRG 443 (455)
T ss_pred HHHHHHHHHHHHHHHhHHHHHhhhc-ccchHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 999999998 566788888887764 8999999999999999999999888876
No 18
>PRK10189 MATE family multidrug exporter; Provisional
Probab=99.88 E-value=2.6e-20 Score=183.09 Aligned_cols=212 Identities=12% Similarity=0.118 Sum_probs=194.6
Q ss_pred HHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 012822 43 ASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (456)
Q Consensus 43 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~ 122 (456)
.+++.+|++++.+.|..++++.......+.+.+++++|++++++++++.++.+ +...+..|+++|.++++++++|++|.
T Consensus 253 ~~~~~~~~il~iG~P~~~~~~~~~~~~~~~~~~~~~~G~~~~Aa~~I~~~i~~-~~~~~~~gi~~A~~~lvg~~~Ga~~~ 331 (478)
T PRK10189 253 LNFAIIWEVMGIGIPASIESVLFNGGKLLTQMFVAGMGTSVIAGNFIAFSIAA-LINLPGNALGSASTIITGTRLGKGQI 331 (478)
T ss_pred CCHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhCCCCH
Confidence 35678999999999999999999999999999999999999999999999999 88889999999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHH
Q 012822 123 EMLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA 201 (456)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 201 (456)
|++++..+.+..++.+.++.++++ +.+.+++..+|.+|+++.+.+..++++.++..++...+.+..+.++|.||++.++
T Consensus 332 ~~a~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~lFt~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~g~lrg~G~t~~~~ 411 (478)
T PRK10189 332 AQAERQLRHVFWLSTLGLTAIAWLSAPFAGLLASFYTQDPDVKHVVKILIWLNALFMPIWAASWVLPAGLKGARDARYAM 411 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHhhcCCCchHHH
Confidence 999999999999999999888865 7889999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHH-HHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhccccc
Q 012822 202 YISAAT-LVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCK 255 (456)
Q Consensus 202 ~~~~~~-~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~ 255 (456)
+.++.+ .++.+++.+++....++|+.|++++..+++.+..++.++.+++.++.+
T Consensus 412 ~i~~~~~~~v~ip~~~ll~~~~~~g~~Gvw~~~~~~~~~~~~~~~~r~~~~~W~~ 466 (478)
T PRK10189 412 WVSMLGMWGCRVVAGYILGIMLGFGVVGVWMGMFLDWAVRGVLFYWRMVSGRWLW 466 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 999988 578888888887766899999999999999999998887777664433
No 19
>PRK01766 multidrug efflux protein; Reviewed
Probab=99.88 E-value=1.7e-20 Score=184.86 Aligned_cols=208 Identities=17% Similarity=0.162 Sum_probs=193.8
Q ss_pred HHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 012822 43 ASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (456)
Q Consensus 43 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~ 122 (456)
.+++..|++++.++|.+++++.......++..+++++|++++++++++.++.+ +...+..|++.+.++.++|++|++|+
T Consensus 233 ~~~~~~k~il~l~~P~~~~~~~~~~~~~~~~~~~~~~G~~~lAa~~i~~~i~~-~~~~~~~gl~~a~~~~v~~~~Ga~~~ 311 (456)
T PRK01766 233 PDWAVIKRLLKLGLPIGLAIFFEVSLFAVVTLLVSPLGTVTVAAHQIALNFSS-LLFMLPLSLAMALTIRVGFELGAGRT 311 (456)
T ss_pred CCHHHHHHHHHccchHHHHHHHHHHHHHHHHHHHHHcChHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhcCCCH
Confidence 45667899999999999999999999999999999999999999999999999 77888999999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHH
Q 012822 123 EMLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA 201 (456)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 201 (456)
+++++..+.+..++..++++.+++ +.+.+++..++..|+++.+.+..++++..+..++..++....+.+++.||++.+.
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~~~l~g~g~~~~~~ 391 (456)
T PRK01766 312 LDARQYAYIGLAVGLGMALLTAIFLVLFREQIALLYTDDPEVVALASHLLLFAALFQFSDAIQVIGSGALRGYKDTRVIF 391 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhchhccCccHHHH
Confidence 999999999999999999888755 7889999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHH-HHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 012822 202 YISAATL-VLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (456)
Q Consensus 202 ~~~~~~~-~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (456)
..++++. ++++++.+++.+..++|+.|+++++.+++++..++.++++++.
T Consensus 392 ~~~~~~~~~~~i~~~~~l~~~~~~G~~G~~~~~~~~~~~~~~~~~~~~~~~ 442 (456)
T PRK01766 392 FITFIAYWVLGLPLGYILALTDPMGPFGFWIGLIIGLTAAAILLLLRLRKL 442 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCCceehHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999986 7899999988877679999999999999999999888777654
No 20
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=99.86 E-value=9.6e-20 Score=178.69 Aligned_cols=207 Identities=14% Similarity=0.215 Sum_probs=189.0
Q ss_pred HHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccCh-hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCC
Q 012822 42 IASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGN-LELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAG 120 (456)
Q Consensus 42 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~-~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~ 120 (456)
+.+++..|++++.+.|..+.+....+...+.+.+++++|+ +++++++++.++.. +...+..|++++.++.++|++|++
T Consensus 227 ~~~~~~~~~il~ig~P~~~~~~~~~~~~~~~~~~~~~~g~~~~lAa~~i~~~i~~-~~~~~~~gi~~a~~~lvg~~~Ga~ 305 (453)
T PRK09575 227 RFNWSLAPKIVLLGSSSFFMYLYGSFVVALHNRLFMEYGSALTVGAYAIVGYLMV-LYYLVAEGIAEGMQPPVSYYFGAR 305 (453)
T ss_pred CcCHHHHHHHHHhChhHHHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHHHHHHH-HHHHHHHHHHHhhHHHHHHHhcCC
Confidence 3456778999999999999999999999999999999975 68999999999999 888899999999999999999999
Q ss_pred CcchHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCC-CHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCch
Q 012822 121 RYEMLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGE-STAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVL 198 (456)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~-~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~ 198 (456)
|+|++++..+.++.+++..+++.+++ +.+.+++..+++. |+++.+.+.+|+++..++.++..+.....+++|+.||++
T Consensus 306 ~~~~~~~~~~~~l~l~~~~~~~~~~~~~~~~~~i~~lf~~~~~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~~~g~~~ 385 (453)
T PRK09575 306 QYDNIKKLLKLAMKVTVLAGIAWVLLLNLFPETMIALFNSGDSELIAETIVGIRLHLFAMFLDGFLVLASAYFMAVNQGG 385 (453)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcH
Confidence 99999999999999999999988865 7799999999985 788999999999999999999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 012822 199 PSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (456)
Q Consensus 199 ~~~~~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (456)
.++..+....++++++.+++... +|+.|+|+++.+++.+..++...+++++
T Consensus 386 ~~~~~~~~~~~v~ip~~~ll~~~--~G~~Gvw~a~~~~~~~~~~~~~~~~~~~ 436 (453)
T PRK09575 386 KALFISIGNMLIQLPFLFILPKW--LGVDGVWLAMPLSNIALSLVVAPMLWRD 436 (453)
T ss_pred HHHHHHHHhHHHHHHHHHHHHHH--HCcchHhhHHHHHHHHHHHHHHHHHHHH
Confidence 99999998888888888877654 6999999999999999888887766654
No 21
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=99.85 E-value=2.2e-18 Score=172.37 Aligned_cols=206 Identities=17% Similarity=0.149 Sum_probs=185.4
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcc
Q 012822 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYE 123 (456)
Q Consensus 44 ~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~ 123 (456)
+++..|++++.+.|..++++...+...+|+.+.+.+|++++++|+.+.++.++....+..+++++..|.++++.+++|++
T Consensus 218 ~~~~~k~~l~~~~p~~~~~~~~~~~~~id~~~~~~~~~~~v~~~~~a~~l~~~~~~~~~~~i~~~~~P~~s~~~~~~~~~ 297 (502)
T TIGR01695 218 RDPGLKRFLKLFLPTTLGSSASQITLLINTALASFLEIGSVSALYYANRIYQLPLGIFGISLSTVLLPKLSRHASEGNWN 297 (502)
T ss_pred CChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHH
Confidence 45678999999999999999999999999988666799999999999999984444567899999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCC----CHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCch
Q 012822 124 MLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGE----STAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVL 198 (456)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~----~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~ 198 (456)
+.++..+++......++++++++ ..++++++.++.+ |++..+.+..++++.+++.++..+.....+.+++.||+|
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ii~l~~~~~~f~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~a~g~~~ 377 (502)
T TIGR01695 298 ELRDLLNQGIRLSLLLTIPSSFGLLILSIPIVSLLFERGAFSEEDTVMTATILAAYGLGLIFYSLQKVLLRAFYARKDTR 377 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhccCCc
Confidence 99999999999999999998865 7888999887754 557778889999999999999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 012822 199 PSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (456)
Q Consensus 199 ~~~~~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (456)
.+.+.+....++|+++++++++. +|..|+++++.+++.+...+..++.+|+
T Consensus 378 ~~~~~~~~~~~i~i~l~~~l~~~--~G~~G~~~a~~i~~~~~~~~~~~~~~~~ 428 (502)
T TIGR01695 378 TPFINSVISVVLNALLSLLLIFP--LGLVGIALATSAASMVSSVLLYLMLNRR 428 (502)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHH--HhhhHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999998765 6999999999999999999888777664
No 22
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=99.82 E-value=3.5e-18 Score=166.48 Aligned_cols=186 Identities=16% Similarity=0.139 Sum_probs=174.5
Q ss_pred hhHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHH
Q 012822 267 SGICEFLKLSGSSAVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKA 346 (456)
Q Consensus 267 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~ 346 (456)
+..|++++.++|..++++.......+|+.+++++++ +.++++.+++.++..+...+..+++.+..+.++|++|+||+|+
T Consensus 6 ~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~l~g-~~alAa~~l~~~i~~~~~~~~~~~~~g~~~lvsq~~Ga~~~~~ 84 (441)
T PRK10367 6 SSDKALWRLALPMIFSNITVPLLGLVDTAVIGHLDS-PVYLGGVAVGATATSFLFMLLLFLRMSTTGLTAQAFGAKNPQA 84 (441)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC-hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHH
Confidence 447899999999999999999999999999999853 4457799999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHH
Q 012822 347 AAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYV 426 (456)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~ 426 (456)
+++..++++...++++++..+....+.+++.++++.|+|+.+.+.+|+++..++.++..++.....++++.||+|.+++.
T Consensus 85 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ll~~~g~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~~~~ 164 (441)
T PRK10367 85 LARALVQPLLLALGAGALIALLRTPLIDLALHIVGGSEAVLEQARRFLEIRWLSAPASLANLVLLGWLLGVQYARAPVIL 164 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccchHHHHH
Confidence 99999999999999999998888889999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCcceee
Q 012822 427 NIACYYIVGIPLGCLLGFKFNFGAKVKI 454 (456)
Q Consensus 427 ~~~~~~~~~i~l~~~l~~~~~~G~~G~~ 454 (456)
++++ .++++++.+++.+.+++|+.|.+
T Consensus 165 ~ii~-~~vni~l~~~lI~~~~lGv~Gaa 191 (441)
T PRK10367 165 LVVG-NILNIVLDLWLVMGLHMNVQGAA 191 (441)
T ss_pred HHHH-HHHHHHHHHHHHHHcCCccHHHH
Confidence 9998 78899999999988889999875
No 23
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=99.80 E-value=4.2e-16 Score=142.91 Aligned_cols=269 Identities=18% Similarity=0.182 Sum_probs=204.6
Q ss_pred HHhhHHHHHHHHHHHHHHHHHHHHhhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHH
Q 012822 52 VRLAAPAVFVYLINNLMSLSTRVFCGHL-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQ 130 (456)
Q Consensus 52 ~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~~~~~~~~ 130 (456)
+|.+.....+++...+.+++...+++|+ |+|++|.++...++.+++......|++++....+++...+ +++.+.+..
T Consensus 2 ~k~~~~~~~~~~~~~~~~~~~~~il~r~l~~~~~G~~~~~~~~~~~~~~~~~~G~~~~~~r~~~~~~~~--~~~~~~~~~ 79 (273)
T PF01943_consen 2 LKNSLWLFLSNILSALIGFITIPILARYLGPEEYGIYSLALSIVSLLSILADLGLSQAIVRFIAEYKDK--KELRSAYFS 79 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhHHHHHHHHHHHHHHHHHhhhhHHHHHHHHHHhhhh--HHHHHHHHH
Confidence 5678889999999999999999999995 9999999999999999666667999999999988886432 344455555
Q ss_pred HHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhH-HHHHHHHHHHHHHHHHcCCchhHHHHHHHHHH
Q 012822 131 RATFVLLATGVPVMMVYIFCKPMLILLGESTAVASAAALFVYGLIPQ-IFAYAVNFPIQKFLQAQSIVLPSAYISAATLV 209 (456)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 209 (456)
.......+.+++...... +...++.++. .. . ..+.... .+..........++++.++.+.....++...+
T Consensus 80 ~~~~~~~~~~~i~~~~~~----~~~~~~~~~~-~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (273)
T PF01943_consen 80 SVLFLLLIFSLIFLLILL----IASFFGNPSL-SL---I-LIILALLILILSSLSSVFSGLLQGLQRFKYIAISNIISSL 150 (273)
T ss_pred HHHHHHHHHHHHHHHHHH----HHHHcCCchH-HH---H-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 444444333333332222 2123333322 11 1 1222222 25777888899999999999999999999988
Q ss_pred HHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhcccccccccCCChhhHhhHHHHHHHHhHHHHHHHHHHHH
Q 012822 210 LHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLCLETWY 289 (456)
Q Consensus 210 ~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 289 (456)
...++..+++.. +.++.+..++..++..+...+...+.+|+.+ .+ +...+++..|++++++.|..+++....+.
T Consensus 151 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (273)
T PF01943_consen 151 LSLLLILLLLFL-GSSLWGFLLGLVISSLVSLIISLFYLRRKLR--PR---FSFFSKKFFKEILRFGLPLFLSSLLSWLY 224 (273)
T ss_pred HHHHHHHHHHHH-hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHc--cc---ccccchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 888776666655 3458899999999999998888888776532 11 22222466999999999999999999999
Q ss_pred HHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 012822 290 FQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNE 338 (456)
Q Consensus 290 ~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~ 338 (456)
...|.++++.+.+ +.++|.|+++.++......+..++.++..|.+++.
T Consensus 225 ~~~d~~ii~~~~g-~~~vg~Y~~a~~l~~~~~~~~~~~~~~~~P~~s~l 272 (273)
T PF01943_consen 225 SQIDRLIIGYFLG-PEAVGIYSVAYRLASAISFLLSSISTVLFPRLSRL 272 (273)
T ss_pred HHhHHHHHHHhCC-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999865 44588999999999999999999999999999875
No 24
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=99.78 E-value=5.1e-16 Score=151.49 Aligned_cols=206 Identities=20% Similarity=0.190 Sum_probs=190.1
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcc
Q 012822 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYE 123 (456)
Q Consensus 44 ~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~ 123 (456)
..+..|++++...|..++....++...+|+.+.+.+++.++++++.+.++.++....+..++++...|..++...++|.+
T Consensus 193 ~~~~~~~~~~~~~p~~l~~~~~qi~~lv~~~laS~l~~G~vs~l~YA~~l~~lp~~i~~~~i~tv~~P~ls~~~~~~d~~ 272 (451)
T PF03023_consen 193 RDPNLKRFLKLAIPLLLSSSISQINILVDRALASFLGEGSVSALNYAQRLYQLPLGIFAVSISTVVFPKLSRLAAEGDWE 272 (451)
T ss_pred CChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHH
Confidence 44568999999999999999999999999999999999999999999999997777888899999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcC----CCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCch
Q 012822 124 MLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLG----ESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVL 198 (456)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~----~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~ 198 (456)
+.++.+++++...+.+.+|.++. +.++++++.++. .+.+-.+.+...+++.+++.++..+...+...+.+.+|+|
T Consensus 273 ~~~~~~~~~l~~~~~i~iP~~~~~~~~a~~iV~llf~rG~F~~~~~~~ta~~l~~y~~~l~~~~l~~ll~r~fya~~~~~ 352 (451)
T PF03023_consen 273 EFRKTLRKALRLILLILIPASIGLIVLAEPIVRLLFERGAFTAEDTQLTASALRIYALGLPFYALNDLLSRVFYALGDTK 352 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHccCCCCHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHccCcH
Confidence 99999999999999999999965 889999996653 2566677888999999999999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 012822 199 PSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (456)
Q Consensus 199 ~~~~~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (456)
.+.+.++++.++|++++.++... +|..|.++++.++.++..++.+..++|+
T Consensus 353 ~~~~~~~~~~~lni~l~~~l~~~--~g~~Glala~sl~~~i~~~~l~~~l~r~ 403 (451)
T PF03023_consen 353 TPVRISVISVVLNIILSILLVPF--FGVAGLALATSLSAIISALLLYILLRRR 403 (451)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999888876 6999999999999999999998888775
No 25
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=99.76 E-value=2e-18 Score=145.23 Aligned_cols=162 Identities=25% Similarity=0.413 Sum_probs=155.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHH
Q 012822 278 SSAVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSI 357 (456)
Q Consensus 278 p~~~~~~~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 357 (456)
|.+++++...+.+.+++.+++++|+ .++++++++.++.++...+..+++++..+.+++++|++|+|++++..++++.+
T Consensus 1 P~~~~~~~~~~~~~~~~~~~~~~g~--~~~a~~~i~~~~~~~~~~~~~g~~~a~~~~~s~~~G~~~~~~~~~~~~~~~~~ 78 (162)
T PF01554_consen 1 PIALMQLLQVLGFIIDTIFVGRLGP--EALAAYGIASSIFSILFMLIFGLATALQILISQNIGAGDYKRAKKVVRQGLLL 78 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHCCHCCTT--CCCCHCCHHHHHHHHHHHHHHHHHHHHHHHHCCCCCSSSTTTCCCHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhCH--HHHHHHHHHHHHHHHHhhhcccccccccceeeccccccccccccccccccccc
Confidence 7889999999999999999999975 44669999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHHH
Q 012822 358 SFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGIP 437 (456)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~ 437 (456)
...++++.++....+++++.++|++|+++.+.+.+++++..++.++.++.....+++++.||+|..++.++.+.|++++|
T Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~ 158 (162)
T PF01554_consen 79 SLIIGLLLSLVLLLFSEFILSLFGNDPEVIEIARQYLRIMAFSIPFFALFFVFSGILQGIGRTKIAMYISIISFWIINIP 158 (162)
T ss_dssp HHHHHHHHHHHHHHHHHCCHCTSSSTTCCHHHHHHHHCCHHHHHHHHHHHHHHCCCCGCCSTHCCCHHHHHHHHHHHHHH
T ss_pred chhcccchhhhhhhHHHHHHHHhhhhHHHHHHhhccchhhhhHHHHHHHHHHHHHHHHHCCcHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998899999
Q ss_pred HHHH
Q 012822 438 LGCL 441 (456)
Q Consensus 438 l~~~ 441 (456)
++|+
T Consensus 159 l~yl 162 (162)
T PF01554_consen 159 LAYL 162 (162)
T ss_dssp HHHH
T ss_pred HHhC
Confidence 9875
No 26
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=99.75 E-value=2.9e-16 Score=156.55 Aligned_cols=204 Identities=13% Similarity=0.115 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhcc-Ch------h---HHHHH-HHHHHHHHHHHHHHHHHHHHhHHH
Q 012822 43 ASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHL-GN------L---ELAAA-SLGNSGIQLFAYGLMLGMGSAVET 111 (456)
Q Consensus 43 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~------~---~~~~~-~~~~~i~~~~~~~~~~g~~~a~~~ 111 (456)
.+++.+|++++++.|.+++++...+...+|+.++++. ++ + .+|.+ +.+.++.. +...+..+++++..|
T Consensus 219 ~~~~~~k~l~~~~~p~~l~~~~~~~~~~~d~~ii~~~l~~~g~~~~~a~~~~g~~~~~a~~i~~-~~~~~~~~l~~~~~p 297 (488)
T TIGR02900 219 EGKALLFDLFSVSLPLTLSRFIGSLLYFLETLLVPQRLVIAGVTYREATSLYGKLSGMAMPLLT-FPAVITSSLSTALVP 297 (488)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHChHHHHHH-hHHHHHHHHHHHHHH
Confidence 3456889999999999999999999999999999874 22 1 22333 34556666 556778999999999
Q ss_pred HHHhhhcCCCcchHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHH
Q 012822 112 LCGQAYGAGRYEMLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKF 190 (456)
Q Consensus 112 ~vs~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~ 190 (456)
.+++..|++|+|+.++..++...+...++++.+++ ..+.++++.++..++ ++..++++.++..++..+....++.
T Consensus 298 ~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~----~~~~~l~i~~~~~~~~~~~~~~~~~ 373 (488)
T TIGR02900 298 DISEAMAKKNYSSIEKRINQAIKISLLLGLITTVILLVIPDELGALFYGRP----DAGNFIRVLAPSFPFLYFSAPLQSI 373 (488)
T ss_pred HHHHHHHcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC----chHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999988865 778888888876543 3567899999999999999999999
Q ss_pred HHHcCCchhHHHHHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 012822 191 LQAQSIVLPSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (456)
Q Consensus 191 l~~~~~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (456)
+++.||+|...+.+++..++|++++++++...++|+.|+++++.+++.+..++..++.+|.
T Consensus 374 l~~~g~~~~~~~~~~~~~i~~i~l~~~l~~~~~~G~~Gaaia~~i~~~~~~~~~~~~~~~~ 434 (488)
T TIGR02900 374 LQGLGKQKVALRNSLIGAIVKIILLFVLTSIPSINIYGYAITFIITSVLVTILNLAEIKKN 434 (488)
T ss_pred HHhcCcchHHHHHHHHHHHHHHHHHHHHHhccccccHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999888732247999999999999999999988777654
No 27
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=99.73 E-value=3e-18 Score=144.10 Aligned_cols=160 Identities=24% Similarity=0.397 Sum_probs=153.5
Q ss_pred HHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHHHHHHHH
Q 012822 57 PAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQRATFVL 136 (456)
Q Consensus 57 p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~~~~~~~~~~~~~~ 136 (456)
|.++++++..+...+|+.+++++|++++++++++.++.+ +...+..|+++|..+.++|++|++|+|++++..+.+..+.
T Consensus 1 P~~~~~~~~~~~~~~~~~~~~~~g~~~~a~~~i~~~~~~-~~~~~~~g~~~a~~~~~s~~~G~~~~~~~~~~~~~~~~~~ 79 (162)
T PF01554_consen 1 PIALMQLLQVLGFIIDTIFVGRLGPEALAAYGIASSIFS-ILFMLIFGLATALQILISQNIGAGDYKRAKKVVRQGLLLS 79 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHCCHCCTTCCCCHCCHHHHHHH-HHHHHHHHHHHHHHHHHCCCCCSSSTTTCCCHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHH-HHhhhcccccccccceeecccccccccccccccccccccc
Confidence 889999999999999999999999999999999999999 8888999999999999999999999999999999999999
Q ss_pred HHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHHHHHHH-HHHHHH
Q 012822 137 LATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATL-VLHLLL 214 (456)
Q Consensus 137 ~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~i~l 214 (456)
..+++++.++ ..+.+++..+++.|+++.+++.+|+++..+..++..+....++++++.||++.....++++. ++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~i~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l 159 (162)
T PF01554_consen 80 LIIGLLLSLVLLLFSEFILSLFGNDPEVIEIARQYLRIMAFSIPFFALFFVFSGILQGIGRTKIAMYISIISFWIINIPL 159 (162)
T ss_dssp HHHHHHHHHHHHHHHHCCHCTSSSTTCCHHHHHHHHCCHHHHHHHHHHHHHHCCCCGCCSTHCCCHHHHHHHHHHHHHHH
T ss_pred hhcccchhhhhhhHHHHHHHHhhhhHHHHHHhhccchhhhhHHHHHHHHHHHHHHHHHCCcHHHHHHHHHHHHHHHHHhH
Confidence 9999999976 88888899999999999999999999999999999999999999999999999999999998 999998
Q ss_pred HHH
Q 012822 215 SWL 217 (456)
Q Consensus 215 ~~~ 217 (456)
+++
T Consensus 160 ~yl 162 (162)
T PF01554_consen 160 AYL 162 (162)
T ss_dssp HHH
T ss_pred HhC
Confidence 874
No 28
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=99.73 E-value=4.1e-14 Score=136.09 Aligned_cols=206 Identities=15% Similarity=0.130 Sum_probs=187.8
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcc
Q 012822 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYE 123 (456)
Q Consensus 44 ~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~ 123 (456)
+.+..|++.+...|..++...+++...+|+.+.+.+.+.+.+.+..+.++.++..-.+..++++...|..|+...++|.+
T Consensus 227 ~~~~lk~~~~~~~p~~l~~sisQi~lli~~~iAS~l~~Gsis~l~YA~rl~qlPlGifgvai~tvllP~lSr~~~~~~~~ 306 (518)
T COG0728 227 KDPGLKRFLKLMLPALLGVSISQINLLIDTAIASFLAEGSVSWLYYADRLYQLPLGIFGVALSTVLLPSLSRHAANGDWP 306 (518)
T ss_pred CchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHhhcCChH
Confidence 33688999999999999999999999999999999999999999999999997777999999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcC----CCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCch
Q 012822 124 MLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLG----ESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVL 198 (456)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~----~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~ 198 (456)
+.++..+.++.++..+++|.+.. ..+++|++..+. .+++-...+.+.++...++.++..+..++...+++.+|+|
T Consensus 307 ~~~~~l~~~i~l~lll~lP~~~~l~~la~piv~~Lf~rG~F~~~d~~~ta~~L~~y~~gL~~~~L~~ll~~~FYAr~d~k 386 (518)
T COG0728 307 EFLKLLDWGLRLTLLLTLPASAGLLVLAEPIVSLLFERGAFTAEDVLMTAEALAAYSLGLIPFALVKLLSRVFYAREDTK 386 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCCCChHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHccCCC
Confidence 99999999999999999999966 889999996652 2345556677889999999999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 012822 199 PSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (456)
Q Consensus 199 ~~~~~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (456)
.++++.+++.++|+.+++.+... +|..|.++++.++.++++.+.++..+|+
T Consensus 387 tP~~i~ii~~~~n~~l~~~l~~~--~~~~giala~s~a~~~~~~ll~~~l~k~ 437 (518)
T COG0728 387 TPMKIAIISLVVNILLNLLLIPP--LGHVGLALATSLAAWVNALLLYYLLRKR 437 (518)
T ss_pred cChHHHHHHHHHHHHHHHHHHhh--ccchHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999777665 6888899999999999999998888775
No 29
>PRK10459 colanic acid exporter; Provisional
Probab=99.72 E-value=2.3e-14 Score=142.80 Aligned_cols=201 Identities=17% Similarity=0.073 Sum_probs=171.9
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 012822 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHL-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (456)
Q Consensus 44 ~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~ 122 (456)
+++..|++++++.|...+++...+...+|+.+++++ |++++|.|+.+.++.++....+...+++...|..++. ++|+
T Consensus 202 ~~~~~k~ll~~~~~~~~~~~~~~~~~~~d~~~lg~~lg~~~vG~Y~~A~~l~~~~~~~i~~~i~~v~~P~~s~~--~~~~ 279 (492)
T PRK10459 202 SLASVKPNLSFGAWQTAERIINYLNTNIDTILIGRILGAEVLGGYNLAYNVATVPPMKINPIITRVAFPVFAKI--QDDT 279 (492)
T ss_pred cHHHHHHHHhhhHHHHHHHHHHHHHhcCchhhhhHhhchHhhhhHHHHHHHHHHHHHHHHHHHHHHHhHHHHHh--cCCH
Confidence 356689999999999999999999999999999996 9999999999999998445556666788888999885 5788
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHH
Q 012822 123 EMLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA 201 (456)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 201 (456)
++.++.+.+...+...+++|+.++ ..++++++.++.+++ +..+...++++++...+..+.......+++.||+|...
T Consensus 280 ~~~~~~~~~~~~~~~~~~~p~~~~l~~~a~~ii~ll~g~~--~~~a~~~l~il~~~~~~~~~~~~~~~~l~a~g~~~~~~ 357 (492)
T PRK10459 280 EKLRVGFLKLLSVLGIINFPLLLGLMVVSNNFVPLVFGEK--WNSAIPILQLLCIVGLLRSVGNPIGSLLLAKGRADLSF 357 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhcChh--HHhHHHHHHHHHHHHHHHHHHHHHHHHHHHcCccchhH
Confidence 889999999999999999988865 778888887765543 45677889999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHh
Q 012822 202 YISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILM 250 (456)
Q Consensus 202 ~~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~ 250 (456)
..+++..+++++..+.+... +|+.|+++++.+++.+...+..++..|
T Consensus 358 ~~~~~~~~~~i~~~~~~~~~--~G~~g~a~a~~i~~~~~~~~~~~~~~~ 404 (492)
T PRK10459 358 KWNVFKTFLFIPAIVIGGQL--AGLIGVALGFLLVQIINTILSYFLMIK 404 (492)
T ss_pred HHHHHHHHHHHHHHHHHHhh--ccHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99988888887776665543 699999999999999988888777744
No 30
>PRK15099 O-antigen translocase; Provisional
Probab=99.69 E-value=1.2e-14 Score=141.50 Aligned_cols=202 Identities=8% Similarity=-0.033 Sum_probs=173.5
Q ss_pred HHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhh-ccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCC
Q 012822 42 IASWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCG-HLGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAG 120 (456)
Q Consensus 42 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~-~~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~ 120 (456)
+.+++..|++++++.|..++++...+....|+.+++ ++|++++|.|+.+.++.+.+...+..+++++..|.++++ +
T Consensus 208 ~~~~~~~k~ll~~g~p~~~~~~~~~i~~~~~~~~l~~~~g~~~vg~y~~a~~i~~~~~~~~~~~~~~a~~P~~s~~---~ 284 (416)
T PRK15099 208 SWDNGLAGQLGKFTLMALITSVTLPVAYVMMRNLLAAHYSWDEVGIWQGVSSISDAYLQFITASFSVYLLPTLSRL---T 284 (416)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---C
Confidence 345678899999999999999999999999999997 579999999999999988455788999999999999995 5
Q ss_pred CcchHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchh
Q 012822 121 RYEMLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLP 199 (456)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~ 199 (456)
|+|+.++..++.......++.+.+++ .+++++++.++.+++ .+++.+++++.+++.++...+......+.+.++.+.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~a~~ii~l~~g~~--~~~~~~~~~~l~~~~~l~~~~~~~g~~~~~~~~~~~ 362 (416)
T PRK15099 285 EKRDITREIVKALKFVLPAVAAASFTVWLLRDFAIWLLFSNK--FTAMRDLFAWQLVGDVLKVGAYVFGYLVIAKASLRF 362 (416)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 67888888999998888888887765 688999998887654 233677888988888888888877777778888888
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHh
Q 012822 200 SAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILM 250 (456)
Q Consensus 200 ~~~~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~ 250 (456)
.....+...++++++++++++. +|..|+++++.+++.+...+..+...+
T Consensus 363 ~~~~~~~~~~l~i~l~~~li~~--~G~~G~a~a~~is~~~~~~~~~~~~~~ 411 (416)
T PRK15099 363 YILAEVSQFTLLTGFAHWLIPL--HGALGAAQAYMATYIVYFSLCCGVFLL 411 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHH--hhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 8888888889999999999987 699999999999999999888765554
No 31
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=99.67 E-value=8e-15 Score=139.17 Aligned_cols=174 Identities=18% Similarity=0.224 Sum_probs=159.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHH
Q 012822 278 SSAVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSI 357 (456)
Q Consensus 278 p~~~~~~~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 357 (456)
|.++++....+...+++.+++++++ .++++|+.+.++..+...+..+++++..|.++++.|++|+|++++..++....
T Consensus 1 p~~~~~~~~~~~~~~~~~~~~~~g~--~~~~~~~~a~~i~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~ 78 (342)
T TIGR00797 1 PAILANILQPLLGLVDTAFVGHLGP--VDLAAVSLGSSVFMFLFSILMGLGTATTALVAQAVGAGNYQRLGRQAQQSLLL 78 (342)
T ss_pred ChHHHHHHHHHHHHHHHHHHhcccH--HHHHHHHHhHHHHHHHHHHHHHHHHhHHHHHHHHHCCCChHHHHHHHHHHHHH
Confidence 6788889999999999999999984 34679999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHHH
Q 012822 358 SFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGIP 437 (456)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~ 437 (456)
...++++.++++.++++++.++++.|++..+.+..++++++++.++.+++.....++++.||.+...+.++++ .+++++
T Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~i~~-~~~~i~ 157 (342)
T TIGR00797 79 ALLLGLPVLLVGYFFIDPLLSLMGADGEVAELAQDYLRILILGIPAYLLNFVLRGFLRGQGDTKTPMYITLIG-NVINII 157 (342)
T ss_pred HHHHHHHHHHHHHHhHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchHHHHHHHHH-HHHHHH
Confidence 9999999999999999999999987788888999999999999999999999999999999999999999987 677888
Q ss_pred HHHHHHh-hcC-CCcceee
Q 012822 438 LGCLLGF-KFN-FGAKVKI 454 (456)
Q Consensus 438 l~~~l~~-~~~-~G~~G~~ 454 (456)
+.+++.+ .++ +|+.|++
T Consensus 158 ~~~~li~~~~g~~g~~g~~ 176 (342)
T TIGR00797 158 LNYILIFGKFGFLGIVGAA 176 (342)
T ss_pred HhHHHHhcCccccccHHHH
Confidence 8888887 666 6777754
No 32
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=99.64 E-value=1e-12 Score=118.82 Aligned_cols=247 Identities=18% Similarity=0.162 Sum_probs=176.4
Q ss_pred HHHHHHHHhhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHHHHHHHHHHHHHHHHHH
Q 012822 68 MSLSTRVFCGH-LGNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQRATFVLLATGVPVMMV 146 (456)
Q Consensus 68 ~~~i~~~~i~~-~g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (456)
.+++...+++| +|++++|.|+....+..+.......|+++.... ..++|+++.++..+.......+.+.+..++
T Consensus 3 ~~f~~~~~lar~l~~~~~G~~~~~~s~~~~~~~~~~~g~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (251)
T PF13440_consen 3 INFLFLILLARYLGPEDFGIYALIFSIVSILSIVASLGLRQSLVR-----SAARDKQDIRSLLRFSLLVSLLLAVILAIL 77 (251)
T ss_pred HHHHHHHHHHHHCCHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHH-----hhccCHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 45667788888 499999999999999995555557777777544 233556666666666655544444333322
Q ss_pred HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHHHHHHHHHHHHHHHHHHHhhCCcc
Q 012822 147 YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVLHLLLSWLVVYKFGAGL 226 (456)
Q Consensus 147 ~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~ 226 (456)
. ..+...+ .+++ ...++....+..+.........+.+++++|.+..........+....+..++... +.+.
T Consensus 78 ~---~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 148 (251)
T PF13440_consen 78 A---ILIAYFF-GDPE----LFWLLLLLALAIFFSALSQLFRSILRARGRFRAYALIDIVRSLLRLLLLVLLLYL-GLNL 148 (251)
T ss_pred H---HHHHHHh-CChh----HHHHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHHHHHHHHHHH-HhhH
Confidence 1 1111233 3332 2234556677788889999999999999999999999999988875554444443 3588
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHhcccccccccCCChhhHhhHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhcCCcHHHH
Q 012822 227 IGASLVLSLSWYIIVGAQFAYILMSDKCKHTWTGFSVQAFSGICEFLKLSGSSAVMLCLETWYFQILVLIAGLLDNPELA 306 (456)
Q Consensus 227 ~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~a 306 (456)
.+..++..++..+..+..+...+++ .+. . . + .+..| .++.+.|....+...+...+.+.++++.+-+ ..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~-~--~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-~~~ 218 (251)
T PF13440_consen 149 WSILLAFIISALLALLISFYLLRRK--LRL--S-F--K-FSWRR-LLKYGLPFSLSSLLSWLLSQIDRLLIGYFLG-PEA 218 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhccc--cCC--C-c--h-hhHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC-HHH
Confidence 8888998888888777766533321 111 1 1 1 12234 7999999999999999999999999999332 445
Q ss_pred HHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHH
Q 012822 307 LDSLSVCMAVSGLLF-MVSVGFNAAASVRVSNE 338 (456)
Q Consensus 307 v~~~~~~~~i~~~~~-~i~~~i~~~~~p~~~~~ 338 (456)
+|.|+.+.++...+. .+..++++...|.++++
T Consensus 219 ~g~y~~a~~l~~~~~~~~~~~i~~~~~p~lar~ 251 (251)
T PF13440_consen 219 VGIYSVAQRLASLPASLLSSAISSVFFPKLARM 251 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCC
Confidence 779999999999888 89999999999999863
No 33
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=99.61 E-value=3.2e-13 Score=134.32 Aligned_cols=187 Identities=21% Similarity=0.262 Sum_probs=169.5
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 012822 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHL-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (456)
Q Consensus 44 ~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~ 122 (456)
..+..|+.++.+.|..++.+...+.+.+|+.+++++ |++++|.|+.+.++.. ....+...++....|.+++...++|+
T Consensus 208 ~~~~~~~~l~~~~p~~~~~~~~~l~~~~D~~~i~~~l~~~~vG~Y~~a~~i~~-~~~~~~~~l~~~l~P~~s~~~~~~~~ 286 (480)
T COG2244 208 SLALLKELLRFGLPLLLSSLLNFLFTNIDTLLLGLFLGPAQVGIYSAAQRLVS-LLLIVASALNRVLFPALSRAYAEGDR 286 (480)
T ss_pred hhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHhhhhHheecccccHHHH-HHHHHHHHHHHHHHHHHHHHHHcCcH
Confidence 467899999999999999999999999999999996 9999999998888888 88889999999999999999999999
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHH
Q 012822 123 EMLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA 201 (456)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 201 (456)
++.++..++...+....+++..++ ..+.++++..+.+++.. .+...+++.++..++..+.......+++.|+.+...
T Consensus 287 ~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~i~~~fg~~~~--~~~~~l~il~~~~~~~~~~~~~~~~l~~~g~~~~~~ 364 (480)
T COG2244 287 KALKKLLRQSLKLLLLISIPALLGLLLLAPPIITLLFGEKYA--SAAPILQLLALAGLFLSLVSLTSSLLQALGKQRLLL 364 (480)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhheeecCCccc--chhHHHHHHHHHHHHHHHHHHHHHHHHHcCcchhhH
Confidence 999999999999999999999976 78888888776555432 267788999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHH
Q 012822 202 YISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLS 236 (456)
Q Consensus 202 ~~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~ 236 (456)
..+.++.++|+++++++++. +|..|++.++ .+
T Consensus 365 ~~~~~~~i~~~~l~~~li~~--~g~~g~~~a~-~~ 396 (480)
T COG2244 365 LISLISALLNLILNLLLIPR--FGLIGAAIAT-AS 396 (480)
T ss_pred HHHHHHHHHHHHHHhHHHHh--hhhhhHHHHH-HH
Confidence 99999999999999999986 6899999988 44
No 34
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=99.15 E-value=1.1e-07 Score=94.08 Aligned_cols=400 Identities=11% Similarity=0.026 Sum_probs=228.1
Q ss_pred HHhhHHHHHHHHHHHHHHHHHHHHhhc-cChhHHHHHHHHHHHHH-HHHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHH
Q 012822 52 VRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLELAAASLGNSGIQ-LFAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYM 129 (456)
Q Consensus 52 ~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~~~~~~~~~i~~-~~~~~~~~g~~~a~~~~vs~~~g~~~~~~~~~~~ 129 (456)
.+.+.-.++.|+...+.+++.+.++-| ++|+.+|..++=..+.. .+....=-++-.|.+..-.+...++|.++..+..
T Consensus 4 ~~gas~li~lQl~sRllTFvlN~lllR~lsp~ilGi~nv~LeLl~sTILFlSRE~fR~A~lR~~~~~~~~~~~~~~~n~~ 83 (549)
T PF04506_consen 4 AKGASFLILLQLLSRLLTFVLNQLLLRFLSPEILGIANVQLELLYSTILFLSREAFRRACLRQPSSSIDKSNWAQSINLL 83 (549)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHhCCHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCCcccCcccHHHhhhcc
Confidence 345667788899999988887777766 59999998855444443 3445555677777555433321112222333322
Q ss_pred HHHHHHHHHHHHHHHHHHH--hh--HHH--HHHcCCC-HH---HHHHHHHHHHHHHhHHHHHHHHHH----HHHHHHHcC
Q 012822 130 QRATFVLLATGVPVMMVYI--FC--KPM--LILLGES-TA---VASAAALFVYGLIPQIFAYAVNFP----IQKFLQAQS 195 (456)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~--~~--~~i--~~~~~~~-~~---~~~~~~~~l~i~~~~~~~~~~~~~----~~~~l~~~~ 195 (456)
+....+..++.++++.+++ .. ..+ ..+...+ ++ ..+.....+.+...+...-.+.+. .+..+.-..
T Consensus 84 wls~~lq~vvn~~~~~I~l~~igi~~~~~~~~~~~~~~~~~~~~~p~~~~~v~l~~~s~~iELlsEP~~il~Q~~l~~~~ 163 (549)
T PF04506_consen 84 WLSVPLQAVVNLICSYIWLAWIGIPLSILLSQYQYASISNAFVIEPYFEPSVFLYGLSAFIELLSEPLYILAQQMLFFKL 163 (549)
T ss_pred cccCcchhheehhHHHHhHhhccccHHHHHHHHHhhcchhhHHhhhhHHHHHHHHHHHHHHHHhhhHHHHHHHHHhhhhe
Confidence 2222233333332222211 11 111 1111111 11 112222223334444443333333 344555555
Q ss_pred CchhHHHHHHHHHHHHHHHHHHHHHh-hCCcc-----c-hhHHHHHHHHHHHHHHHHHHHHhc--cc---ccccccCCCh
Q 012822 196 IVLPSAYISAATLVLHLLLSWLVVYK-FGAGL-----I-GASLVLSLSWYIIVGAQFAYILMS--DK---CKHTWTGFSV 263 (456)
Q Consensus 196 ~~~~~~~~~~~~~~~~i~l~~~li~~-~~~g~-----~-g~~~a~~i~~~i~~~~~~~~~~~~--~~---~~~~~~~~~~ 263 (456)
|.+.-........+.+..+....... .+++. . -+.++..+++....+......... .. .+...++...
T Consensus 164 Rv~~E~~A~~~k~i~t~~~v~~~~~~~~~~~~~~~~~~~~~~l~Falgq~~ys~~l~~~y~~~~~~~~~~~s~~lp~i~~ 243 (549)
T PF04506_consen 164 RVKAESLAVFAKCIVTFALVVLAERSGYGFFYFLSGQEGLAILAFALGQLAYSITLFFCYYWMYFFPFKSFSDLLPKISS 243 (549)
T ss_pred eeEechHHHHHHHHHHHHHHHHHHhcccceeeeeccchhHHHHHHHHHHHHHHHHHHhhHHhhccCcccchhhccccccc
Confidence 66665555555555555443333211 01111 1 123455556655544332222111 11 1111111111
Q ss_pred h---hHhhHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhc--CCc-HHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHH
Q 012822 264 Q---AFSGICEFLKLSGSSAVMLCLETWYFQILVLIAGL--LDN-PELALDSLSVCMAVSGLLF-MVSVGFNAAASVRVS 336 (456)
Q Consensus 264 ~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~-~~~av~~~~~~~~i~~~~~-~i~~~i~~~~~p~~~ 336 (456)
. ....-+++++........+....+..+.+.+++.. +.+ +++ |.|.++++..+++. .+...+..+.....+
T Consensus 244 ~~~~~~~fd~~~l~l~~~~~~Qsi~K~lLTEGdk~vl~~~~~~t~~~Q--GvY~lv~N~GSLvaR~lF~PiEEs~~~~Fs 321 (549)
T PF04506_consen 244 GNPKSYYFDRDLLSLTWSFFFQSILKHLLTEGDKLVLSFFNLLTFEDQ--GVYALVSNYGSLVARLLFQPIEESSRLYFS 321 (549)
T ss_pred cccccccCCHHHHHHHHHHHHHHHHHHHHhhCCeEEEEeeccCCHHHh--hHHHHHhhHHHHHHHHHhCcHHHHHHHHHH
Confidence 0 11124788888889999999999999999998888 554 444 59999999998665 446668888888888
Q ss_pred HHhcCCCh---------HHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHH
Q 012822 337 NELGAGNP---------KAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQ 407 (456)
Q Consensus 337 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 407 (456)
+...+++. ++..+.+...++....+++.+...-...++.+.+++.+++=....+...++.++...++.++|
T Consensus 322 k~l~~~~~~~~~~~~~~~~~~~~l~~ll~~~~~~gl~~~~fG~~~s~~lL~~~~g~~w~~~~~~~~l~~yc~yi~~la~N 401 (549)
T PF04506_consen 322 KLLSRDNSKKKQPQESLKQAANVLSNLLKFYLYLGLVIVAFGPPYSPLLLRLLGGSRWSSTSAPSLLRAYCYYIPFLAIN 401 (549)
T ss_pred HHhcccCchhhccchhHHHHHHHHHHHHHHHHHHHHHHHHhChhhHHHHHHHHhhhcccCCCchHHHHHHHHHHHHHHHc
Confidence 88765433 335556666667777776666666666666777776554322333578899999999999999
Q ss_pred HHHHHHhhccCcchhHHHHHH--HHHHHHHHHHHHHHHhhcCCCcceee
Q 012822 408 PVLSGVAVGCGWQAFVAYVNI--ACYYIVGIPLGCLLGFKFNFGAKVKI 454 (456)
Q Consensus 408 ~~~~~~l~~~g~~~~~~~~~~--~~~~~~~i~l~~~l~~~~~~G~~G~~ 454 (456)
.+...+.++....+.....+. ..+.++.+..++++..+ ++|..|++
T Consensus 402 Gi~EaF~~s~a~~~~l~~~~~~m~~~S~~f~~~~~~l~~~-~~G~~GlI 449 (549)
T PF04506_consen 402 GITEAFVFSVASESQLDRYNYWMVVFSAIFLAASYLLTRW-GLGAVGLI 449 (549)
T ss_pred cHHHHHHHHhCCHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cCCCchHH
Confidence 999999999988776543332 12255566788888887 78999875
No 35
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=99.11 E-value=4.6e-07 Score=83.87 Aligned_cols=396 Identities=11% Similarity=0.029 Sum_probs=223.0
Q ss_pred HHHHHHhhHHHHHHHHHHHHHHHHHHHHhhc-cChhHHHHHHHHHHHHH-HHHHHHHHHHHHhHHHHHHhhhcCCCcchH
Q 012822 48 LKLLVRLAAPAVFVYLINNLMSLSTRVFCGH-LGNLELAAASLGNSGIQ-LFAYGLMLGMGSAVETLCGQAYGAGRYEML 125 (456)
Q Consensus 48 ~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~~~~~~~~~i~~-~~~~~~~~g~~~a~~~~vs~~~g~~~~~~~ 125 (456)
..+..+.+.-.+..|+...+.++..+.++-| ++++.+|..++-..+.+ .+....--++..|..+.-++. +++.++.
T Consensus 7 L~ss~~ga~~~i~~Q~~~RiiTF~lN~~liR~~s~~v~gi~nvrl~lL~sTiLFlsREair~A~l~~gs~~--~d~~te~ 84 (530)
T KOG2864|consen 7 LESSFSGAVFSIRGQLLARIITFALNALLIRFLSPEVLGIVNVRLELLQSTILFLSREAIRLAELRIGSEP--ADTWTEF 84 (530)
T ss_pred HHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHcChhheehhHHHHHHHHHHHHHhhHHHHHHHhccCCCCC--CccHHHH
Confidence 4445566677777888888777776666555 69999999987776655 333334445555533332221 1233455
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHH-HHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHHH
Q 012822 126 GVYMQRATFVLLATGVPVMMVYIFCKPMLILLGESTA-VASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYIS 204 (456)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 204 (456)
.+..+.+..+.++...++.-+++....-. |+. ..+.-..-+.+..++...--+.+.+.-..|..-+.+...+..
T Consensus 85 ~n~~wlS~~L~~~i~~~~i~~wl~~~~s~-----d~i~~~p~y~~~I~~~~~S~vvELlsEp~~iv~Q~~~~~~~~~i~e 159 (530)
T KOG2864|consen 85 INLLWLSVPLQTAINVACIYFWLGFLSSS-----DEISYSPLYAFAIFIIGLSIVVELLSEPLYIVSQCGLKVQLRAIAE 159 (530)
T ss_pred HHhhhhhhhHHHHHHHHHHHHHHHHhhcc-----chhhcCchHhHHHHHHHHHHHHHHhcccHHHHHHHHHHHHHHHHHh
Confidence 55555555555555544443322111000 100 111111112333333444444444455556666666666666
Q ss_pred HHHHHHHHHHHHHHHHhh--CCccchhHHHHHHHHHHHHHHHHHHHHhccccccc----------ccCCChh--hHhhHH
Q 012822 205 AATLVLHLLLSWLVVYKF--GAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKHT----------WTGFSVQ--AFSGIC 270 (456)
Q Consensus 205 ~~~~~~~i~l~~~li~~~--~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~~----------~~~~~~~--~~~~~~ 270 (456)
-+..++.-...+..+... .+++..-++|.....+...++.++++.+.++-++. .++...+ ..---+
T Consensus 160 ~l~~~v~~i~~fa~lv~~~~~~~l~~FAlaql~~~itl~l~y~~~Yf~~~~s~~~~~~~~r~Sdllpk~~~n~~~~ffd~ 239 (530)
T KOG2864|consen 160 GLATIVKCIVLFAGLVMGPNMYALLAFALAQLAYAITLLLCYYWFYFYIRGSIPETEPFSRFSDLLPKVSENERGIFFDN 239 (530)
T ss_pred HHHHHHHHHHHHHHHHhcCchhHHHHHHHHHHHhhHHHHHHHHHHHHHHcCCcccccchhhhhhhccCCCCCCccccccH
Confidence 666665533333333321 13444444544444444444333333332220000 1111111 001134
Q ss_pred HHHHHHhHHHHHHHHHHHHHHHHHHHHhcC---CcHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHhcCCChHH
Q 012822 271 EFLKLSGSSAVMLCLETWYFQILVLIAGLL---DNPELALDSLSVCMAVSGLLF-MVSVGFNAAASVRVSNELGAGNPKA 346 (456)
Q Consensus 271 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~av~~~~~~~~i~~~~~-~i~~~i~~~~~p~~~~~~~~~~~~~ 346 (456)
+..+........++...+...-+..+++.. ..++++ .|...++..++.. ++...+-.......++...+++.|+
T Consensus 240 d~~~~~~s~~~Qs~lKqlLTeGdkyvmt~~~~ls~~~Qg--vYd~v~n~GSLlaR~iF~PIEEss~~~FA~~ls~~~qe~ 317 (530)
T KOG2864|consen 240 DLLKLTKSFTFQSFLKQLLTEGDKYVMTFTELLSFGDQG--VYDLVSNYGSLLARLIFRPIEESSYIYFARLLSRDNQEN 317 (530)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccceeEeeeccCCcchhh--HHHHHHhhhhHHHHHHhChhHHHHHHHHHHHhhccchhh
Confidence 556666666777777888888777777744 235776 9999988887554 4566788888888888877666665
Q ss_pred HHHH---HHHHHHHHHHHHHHHHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhH
Q 012822 347 AAFS---VVVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFV 423 (456)
Q Consensus 347 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~ 423 (456)
.|+. +...++....+++.+...-...++.+..++++++=....+...++++++..++.+++.+..++.++.++.+..
T Consensus 318 ~k~a~~vL~~lLklv~~igli~~~FG~~YS~~vL~lygG~kwss~~~~~lL~~YclYI~~lAiNGitEaF~~A~~t~~qi 397 (530)
T KOG2864|consen 318 VKKAVDVLSNLLKLVIYIGLIFITFGPAYSYVVLLLYGGSKWSSGGGSLLLSWYCLYIPFLAINGITEAFAFAVATSRQI 397 (530)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcCccccHHHHHHHcCccccCCCchHHHHHHHHHHHHHHhccHHHHHHHHhccHHHH
Confidence 5544 4455666666665555555566677888776644222335578999999999999999999999998877665
Q ss_pred HHHHH--HHHHHHHHHHHHHHHhhcCCCcceee
Q 012822 424 AYVNI--ACYYIVGIPLGCLLGFKFNFGAKVKI 454 (456)
Q Consensus 424 ~~~~~--~~~~~~~i~l~~~l~~~~~~G~~G~~ 454 (456)
..-+- ..+-++.+.++|++..++ |..|++
T Consensus 398 ~~~n~~mlafSviflilsylL~~~~--~~~GlI 428 (530)
T KOG2864|consen 398 DKHNKFMLAFSVIFLILSYLLIRWF--GLVGLI 428 (530)
T ss_pred HhcccchhHHHHHHHHHHHHHHHHh--chhHHH
Confidence 33221 112445567888888876 556653
No 36
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Probab=99.09 E-value=6.3e-09 Score=101.21 Aligned_cols=184 Identities=15% Similarity=0.148 Sum_probs=166.7
Q ss_pred HhhHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHhcCCCh
Q 012822 266 FSGICEFLKLSGSSAVMLCLETWYFQILVLIAGLLDNPELALDSLSVCMAVSGL-LFMVSVGFNAAASVRVSNELGAGNP 344 (456)
Q Consensus 266 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~av~~~~~~~~i~~~-~~~i~~~i~~~~~p~~~~~~~~~~~ 344 (456)
..+.|++.+++.|.++....+.....++...++++|+.+. ++.+++++..+. ...+..++.++..|..+|++|++++
T Consensus 24 ~~e~k~l~~ia~P~i~~~~~~~~~~~is~~f~GhlG~leL--aa~sla~s~~n~~~~s~~~gl~~aletlcgQa~ga~~~ 101 (473)
T KOG1347|consen 24 VTESKELARLALPAILTFLAQPLLSLVSTAFAGHLGNLEL--ASVSLANSFANITGVSILLGLQLALDTLCGQAFGAKKF 101 (473)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhHHhhhccccchHH--HHHHHHHHhhcccchHHhhccchhhhcchHhhhccccc
Confidence 4678999999999999999999999999999999997654 499998888876 4557889999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHH
Q 012822 345 KAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVA 424 (456)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 424 (456)
+.......++........++.+.... +.+++...+..|+++...+..+.++.....+.++........+++.+++....
T Consensus 102 ~~lg~~lqrs~~~l~~~~~~~~~l~~-~~~~il~~lgq~~~i~~~a~~y~~~~ip~~~a~~~~~~l~~~lq~Q~~~~~~~ 180 (473)
T KOG1347|consen 102 TALGVYLQRSGIVLLVQGLPISLLIL-NSEPILLLLGQDPDISRDAGSYAFMLIPGLFSYAVSFPLAKFLQAQSITLPLL 180 (473)
T ss_pred chhhHHHHHHHHHHHHHHHHHHHHHH-ccHHHHHHhCCChhHHHHHhhhHhhhcchhhhhHHHHHHHHHHHhccCchHHH
Confidence 99999999999999988888766554 55899999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCCCccee
Q 012822 425 YVNIACYYIVGIPLGCLLGFKFNFGAKVK 453 (456)
Q Consensus 425 ~~~~~~~~~~~i~l~~~l~~~~~~G~~G~ 453 (456)
++..++ ..+.+++++++.+..++|..|.
T Consensus 181 ~~~~~~-~~lhi~~~~llv~~~~~g~~Ga 208 (473)
T KOG1347|consen 181 VIGLVA-LVLHILLTWLLVSKLGLGIKGA 208 (473)
T ss_pred HHHHHH-HHHHHHHHHHhhhcccCCCccc
Confidence 999888 9999999999999999998775
No 37
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=99.07 E-value=1.1e-06 Score=78.07 Aligned_cols=313 Identities=13% Similarity=0.070 Sum_probs=187.7
Q ss_pred HHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhcc--Ch-hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc
Q 012822 46 LELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHL--GN-LELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY 122 (456)
Q Consensus 46 ~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~--g~-~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~ 122 (456)
...+++.++-+|..+++++..+...+.+.-+++- .+ +.+++|+++.++.- +...+...+-+....++ ++++
T Consensus 8 ~~y~~li~F~iPLa~ts~~~dl~~qiiNagLAr~~e~~vetLAsfglA~sL~l-f~~sp~~~~~~igl~~V-----~s~r 81 (345)
T PF07260_consen 8 TSYWPLIRFFIPLAITSLAMDLGEQIINAGLARVQEDPVETLASFGLAYSLML-FFASPLSMFHHIGLVFV-----NSKR 81 (345)
T ss_pred chHHHHHHHHHHHHHHHHHHhccHHHHHHHHhhccchHHHHHHHHHHHHHHHH-HHhChhhhhHHHHHHHh-----cchh
Confidence 3567899999999999999999999999999874 33 55999999999998 77777777777755555 2332
Q ss_pred chHHHHHHHHHHHHHHHHHHHH-HHHH-hhHHHH-HHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchh
Q 012822 123 EMLGVYMQRATFVLLATGVPVM-MVYI-FCKPML-ILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLP 199 (456)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~i~-~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~ 199 (456)
++.+.+... ...+.+...+.. +.+- +...++ ..++.++++.+.++..+.++.+--++.++...+++++-=++++..
T Consensus 82 srr~~vl~~-~vag~v~avi~~LIa~TpLG~~li~~lhgVs~~va~~tr~a~l~L~llPfl~alr~~~qGILik~r~s~i 160 (345)
T PF07260_consen 82 SRRKAVLCM-AVAGAVAAVIHLLIAWTPLGNYLINDLHGVSPSVAEKTRRAFLYLTLLPFLDALRWIHQGILIKHRHSWI 160 (345)
T ss_pred hhHHHHHHH-HHHHHHHHHHHHHHHhCchHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhhhccceeE
Confidence 332222222 222222222222 2232 233333 567889999999999999999999999999999999887777777
Q ss_pred HHHHHHHHHHHHHHHHHHHHHh-hC--CccchhHHHHHHHHHHHHHH-HHHHHHhcccccccccCCChhhHhhHHHHHHH
Q 012822 200 SAYISAATLVLHLLLSWLVVYK-FG--AGLIGASLVLSLSWYIIVGA-QFAYILMSDKCKHTWTGFSVQAFSGICEFLKL 275 (456)
Q Consensus 200 ~~~~~~~~~~~~i~l~~~li~~-~~--~g~~g~~~a~~i~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (456)
....++...+..+++..+++.. ++ .++.--..+...+..+.+.+ .+.|+..-.+.++.......+....+++++++
T Consensus 161 V~~aSI~~v~~qvV~v~~ll~~~l~~~~pllipil~~y~g~~vr~t~v~LGy~~~i~~~~p~~~~~~~~~~~tl~~~l~F 240 (345)
T PF07260_consen 161 VGSASIADVIAQVVLVAILLSMHLEPQDPLLIPILALYAGIAVRFTIVCLGYYQSIHDIIPQLSGLEKGDSATLQRMLKF 240 (345)
T ss_pred eehHHHHHHHHHHHHHHHHHccccCccccHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhccccCCcccCCChhHHHHHHH
Confidence 7776666655555555455532 11 11111112222233222222 22222222232333333333333568999999
Q ss_pred HhHHHHHHHHHHHHHHHHHHHHhc-CCcH---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHH---
Q 012822 276 SGSSAVMLCLETWYFQILVLIAGL-LDNP---ELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPKAAA--- 348 (456)
Q Consensus 276 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~---~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~--- 348 (456)
.+|.+.........-.+.+.++++ ++.. ..|+++..+.+...-..+....-+- +..|..-+ +++.++.+
T Consensus 241 ~~PL~~~~~tq~~SrplVnl~vsR~l~gs~a~~~avavl~~~ypvgh~~y~w~~~~r-~~~paf~~---~~~~~~~~~~~ 316 (345)
T PF07260_consen 241 WWPLALVLATQRISRPLVNLFVSRDLSGSQAATEAVAVLTATYPVGHMPYGWLTELR-AVYPAFDK---NNPQNKLRNCG 316 (345)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhccCCcccchhhhhhhccccCCCcCcchhHHhHH-hhCchhhc---cCccccccccc
Confidence 999999999999999999999998 4432 2455555554444443333322221 23333322 22223332
Q ss_pred -----HHHHHHHHHHHHHHHHHHHHH
Q 012822 349 -----FSVVVVTSISFIISVVFAVIV 369 (456)
Q Consensus 349 -----~~~~~~~~~~~~~~~~~~~~~ 369 (456)
..+++.....+.+++..+..+
T Consensus 317 ~~v~~~~~~kf~~~c~~~sl~~~f~~ 342 (345)
T PF07260_consen 317 NPVTQSHISKFVVLCLLLSLALCFVM 342 (345)
T ss_pred CchhHHHHHHHHHHHHHHHHHHHHHH
Confidence 255555555555555555443
No 38
>PF14667 Polysacc_synt_C: Polysaccharide biosynthesis C-terminal domain
Probab=98.58 E-value=1.1e-05 Score=66.14 Aligned_cols=79 Identities=16% Similarity=0.243 Sum_probs=73.3
Q ss_pred HHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHHHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHh
Q 012822 171 VYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILM 250 (456)
Q Consensus 171 l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~ 250 (456)
+++.+++.++..+....++.+++.||+|...+.+.++.++|+++++++++. +|..|+++++.+++.+...+..++.+|
T Consensus 2 l~il~~~~~~~~l~~~~~~il~~~~k~~~~~~~~~~~~~v~i~~~~~li~~--~G~~Gaa~a~~i~~~~~~~~~~~~~~k 79 (146)
T PF14667_consen 2 LQILALAIIFMGLSQPLGSILQAMGKTKWPFIITLIGAIVNIILNYILIPR--FGIYGAAIATAISEIVSFILNLWYVRK 79 (146)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHHHH--HHHhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 567888999999999999999999999999999999999999999999876 699999999999999999988888876
Q ss_pred c
Q 012822 251 S 251 (456)
Q Consensus 251 ~ 251 (456)
+
T Consensus 80 ~ 80 (146)
T PF14667_consen 80 K 80 (146)
T ss_pred H
Confidence 5
No 39
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=98.46 E-value=4.3e-05 Score=75.88 Aligned_cols=203 Identities=14% Similarity=0.092 Sum_probs=161.4
Q ss_pred HHHHHHhhHHHHHHHHHHHHHHHHHHHHhhc--c-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCc--
Q 012822 48 LKLLVRLAAPAVFVYLINNLMSLSTRVFCGH--L-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRY-- 122 (456)
Q Consensus 48 ~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~--~-g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~-- 122 (456)
-++.++.......+.+...+.+--|+.+++. + +.++-|.|+++.++-+++.=.+...+-.+.....++...+++.
T Consensus 252 d~~~l~l~~~~~~Qsi~K~lLTEGdk~vl~~~~~~t~~~QGvY~lv~N~GSLvaR~lF~PiEEs~~~~Fsk~l~~~~~~~ 331 (549)
T PF04506_consen 252 DRDLLSLTWSFFFQSILKHLLTEGDKLVLSFFNLLTFEDQGVYALVSNYGSLVARLLFQPIEESSRLYFSKLLSRDNSKK 331 (549)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhCCeEEEEeeccCCHHHhhHHHHHhhHHHHHHHHHhCcHHHHHHHHHHHHhcccCchh
Confidence 3678888999999999999999999999999 6 8999999999999999877788888888888888887765432
Q ss_pred -------chHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHc
Q 012822 123 -------EMLGVYMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQ 194 (456)
Q Consensus 123 -------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~ 194 (456)
++..+.+...+.+...+++++..+ -..++.++.+++++....+.+...++..+..+|+.+++.+..++.++.
T Consensus 332 ~~~~~~~~~~~~~l~~ll~~~~~~gl~~~~fG~~~s~~lL~~~~g~~w~~~~~~~~l~~yc~yi~~la~NGi~EaF~~s~ 411 (549)
T PF04506_consen 332 KQPQESLKQAANVLSNLLKFYLYLGLVIVAFGPPYSPLLLRLLGGSRWSSTSAPSLLRAYCYYIPFLAINGITEAFVFSV 411 (549)
T ss_pred hccchhHHHHHHHHHHHHHHHHHHHHHHHHhChhhHHHHHHHHhhhcccCCCchHHHHHHHHHHHHHHHccHHHHHHHHh
Confidence 235556667777777777666644 666677777766554444556778899999999999999999999988
Q ss_pred CCchhHHHH---HHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 012822 195 SIVLPSAYI---SAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (456)
Q Consensus 195 ~~~~~~~~~---~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (456)
...+..... .....++-+..++++... ++|..|..+|+++...+..+.++.+.++.
T Consensus 412 a~~~~l~~~~~~m~~~S~~f~~~~~~l~~~-~~G~~GlI~AN~iNM~lRI~ys~~fI~~~ 470 (549)
T PF04506_consen 412 ASESQLDRYNYWMVVFSAIFLAASYLLTRW-GLGAVGLILANCINMSLRIIYSLRFIRRY 470 (549)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 776655544 444456666777888776 68999999999999999999998888765
No 40
>COG4267 Predicted membrane protein [Function unknown]
Probab=98.19 E-value=0.005 Score=56.32 Aligned_cols=322 Identities=11% Similarity=0.037 Sum_probs=184.2
Q ss_pred HHHHHHHHHHHhHHHHHHhhhcCCCcchHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHh
Q 012822 97 FAYGLMLGMGSAVETLCGQAYGAGRYEMLGVYMQRATFVLLATGVPVMMVYIFCKPMLILLGESTAVASAAALFVYGLIP 176 (456)
Q Consensus 97 ~~~~~~~g~~~a~~~~vs~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~ 176 (456)
+...++.|++...+..+|...=++|.+++..-+.....+....+.+++...++ ...+... .|=.....
T Consensus 72 fS~IiTgg~q~iiTRfiSD~lF~k~~~kIlpsy~Gvi~lv~~~a~~ig~~vf~-------~~~~~si-----~yk~l~~~ 139 (467)
T COG4267 72 FSQIITGGFQLIITRFISDCLFEKKQRKILPSYIGVILLVTLVAGVIGLIVFF-------VNNQYSI-----VYKILACA 139 (467)
T ss_pred HHHHHhhhHHHHHHHHHHHHHHHHHHHHHhHhHHHHHHHHHHHHHHHHHHhhh-------hcCchhH-----HHHHHHHH
Confidence 55667889999999999999888888888776665555555444444422111 1111111 11112333
Q ss_pred HHHHHHHHHHHHHHHHHcCCchhHHHHHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhcccccc
Q 012822 177 QIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMSDKCKH 256 (456)
Q Consensus 177 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~~~~~~ 256 (456)
.....+..-+...++.+.+|.|.....-.++.++.+.+..++.. .++.|..++..++..+.......+..|.-+-++
T Consensus 140 ~FV~m~~~Wi~~iFlS~lK~y~~iv~sF~iG~~~sv~La~~~~~---~~ie~lLL~~~IGi~~i~~l~~~~Ilr~fk~~~ 216 (467)
T COG4267 140 LFVGMSLVWILMIFLSGLKKYKLIVLSFFIGYVVSVLLARLFLK---SPIEGLLLTLDIGIFIILFLLNFYILRYFKSSR 216 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hHHHHHHHHHHHhHHHHHHHHHHHHHHhccccc
Confidence 34455566667788899999999998888888888887766654 489999999999999888888777776522211
Q ss_pred cccCCChhhHhhHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhcCCcHHHH------HHHHHHHHHHHHHHHHH-----HH
Q 012822 257 TWTGFSVQAFSGICEFLKLSGSSAVMLCLETWYFQILVLIAGLLDNPELA------LDSLSVCMAVSGLLFMV-----SV 325 (456)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~a------v~~~~~~~~i~~~~~~i-----~~ 325 (456)
. ..++.- +..++. ....+-++..++...+++++.=.-++++.- -..|-+.--...+...+ ..
T Consensus 217 ~-i~FdFL--~~~~~y----~SLllIg~FY~lgiwid~FifW~~~~~~~Iag~~~~S~lYDvpiF~ayl~~iPs~vvF~i 289 (467)
T COG4267 217 R-IGFDFL--LYRRKY----PSLLLIGFFYNLGIWIDNFIFWKVPTGIEIAGPFFASPLYDVPIFYAYLFIIPSMVVFLI 289 (467)
T ss_pred c-cceehh--hhhhcc----hHHHHHHHHHHhHhhhhheeeEecCCCCEeecceecchhhhHHHHHHHHHhcchhheeee
Confidence 1 111111 111111 123445566666666666544332211111 01233333332222222 22
Q ss_pred HHHHHHHHHHHHHhc----CC-------ChHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhcccCcHHHHHHHHhHh
Q 012822 326 GFNAAASVRVSNELG----AG-------NPKAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANAVSELC 394 (456)
Q Consensus 326 ~i~~~~~p~~~~~~~----~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l 394 (456)
.+.+...+..-+.+. .+ +.++....+++.+.-..-+-..+++.++++++.+...+.-++ ...+.+
T Consensus 290 ~lET~F~~~Yk~~y~~I~~g~tl~~I~~~~~kMiltlrq~i~~~~~lQ~~a~l~~flL~~~Ll~~~~lS~----~~l~lF 365 (467)
T COG4267 290 SLETDFQENYKEYYQAIRGGGTLREIENNLKKMILTLRQGILEIMELQMLASLLCFLLADALLLWFGLSE----YYLDLF 365 (467)
T ss_pred eeeehHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChHH----HHHHHH
Confidence 233444444322221 12 223344455555555666677788999999999988886543 234455
Q ss_pred HHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHHHHHHHHHhh
Q 012822 395 PLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGIPLGCLLGFK 445 (456)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l~~~l~~~ 445 (456)
++-.++..........-++.--..+-+..+.....- .+.+-.+.++....
T Consensus 366 ~vd~lg~s~~i~f~~ll~i~lyfd~r~i~l~~t~~f-li~N~ilT~i~l~l 415 (467)
T COG4267 366 YVDVLGVSCQIVFMSLLNIFLYFDYRRIALELTALF-LISNGILTFIFLEL 415 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhhhhHH-HHHhHHHHHHHHHh
Confidence 666666666655555555555566666665444443 55666666666543
No 41
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=97.93 E-value=0.0014 Score=61.49 Aligned_cols=200 Identities=15% Similarity=0.115 Sum_probs=147.4
Q ss_pred HHHHhhHHHHHHHHHHHHHHHHHHHHhhcc---ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhcCCCcchHH
Q 012822 50 LLVRLAAPAVFVYLINNLMSLSTRVFCGHL---GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQAYGAGRYEMLG 126 (456)
Q Consensus 50 ~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~---g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~~g~~~~~~~~ 126 (456)
+..+...-..-+.+..++.+--|.++++-. +-++-|.|.++.+.-++..=.+...+........+|...++++|+.+
T Consensus 240 d~~~~~~s~~~Qs~lKqlLTeGdkyvmt~~~~ls~~~QgvYd~v~n~GSLlaR~iF~PIEEss~~~FA~~ls~~~qe~~k 319 (530)
T KOG2864|consen 240 DLLKLTKSFTFQSFLKQLLTEGDKYVMTFTELLSFGDQGVYDLVSNYGSLLARLIFRPIEESSYIYFARLLSRDNQENVK 319 (530)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccceeEeeeccCCcchhhHHHHHHhhhhHHHHHHhChhHHHHHHHHHHHhhccchhhHH
Confidence 444555555666777788888888888753 66678888888888887777777888888777888877766666555
Q ss_pred H---HHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHH-
Q 012822 127 V---YMQRATFVLLATGVPVMMV-YIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSA- 201 (456)
Q Consensus 127 ~---~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~- 201 (456)
+ ++...+.+...++++.... ...++..+.+.+++......+...+++.+..+++.+++.+..+++.+....+...
T Consensus 320 ~a~~vL~~lLklv~~igli~~~FG~~YS~~vL~lygG~kwss~~~~~lL~~YclYI~~lAiNGitEaF~~A~~t~~qi~~ 399 (530)
T KOG2864|consen 320 KAVDVLSNLLKLVIYIGLIFITFGPAYSYVVLLLYGGSKWSSGGGSLLLSWYCLYIPFLAINGITEAFAFAVATSRQIDK 399 (530)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcCccccHHHHHHHcCccccCCCchHHHHHHHHHHHHHHhccHHHHHHHHhccHHHHHh
Confidence 4 4555666666666555533 5666777777776654444455679999999999999999999998877666544
Q ss_pred --HHHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 012822 202 --YISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAYILMS 251 (456)
Q Consensus 202 --~~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (456)
....+..+.-++.++++.-+ +|..|..+|.++...+.-+..+.++++.
T Consensus 400 ~n~~mlafSviflilsylL~~~--~~~~GlIlANiiNm~lRIlys~~fI~~~ 449 (530)
T KOG2864|consen 400 HNKFMLAFSVIFLILSYLLIRW--FGLVGLILANIINMSLRILYSLRFIRHY 449 (530)
T ss_pred cccchhHHHHHHHHHHHHHHHH--hchhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34455567778889999887 5779999999999988888887777764
No 42
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=97.53 E-value=0.00058 Score=62.19 Aligned_cols=72 Identities=17% Similarity=0.119 Sum_probs=67.4
Q ss_pred HHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhh
Q 012822 44 SWLELKLLVRLAAPAVFVYLINNLMSLSTRVFCGHL-GNLELAAASLGNSGIQLFAYGLMLGMGSAVETLCGQA 116 (456)
Q Consensus 44 ~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~~~~i~~~~~~~~~~g~~~a~~~~vs~~ 116 (456)
+++..|++++.+.|..++++...+....|+.+++++ |++++|.|+.+.++.. ....+...+.+...|.+++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ii~~~~g~~~vg~Y~~a~~l~~-~~~~~~~~~~~~~~P~~s~l 272 (273)
T PF01943_consen 200 SKKFFKEILRFGLPLFLSSLLSWLYSQIDRLIIGYFLGPEAVGIYSVAYRLAS-AISFLLSSISTVLFPRLSRL 272 (273)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHhCCHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHh
Confidence 377889999999999999999999999999999996 9999999999999999 88888999999999999875
No 43
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=97.29 E-value=0.063 Score=48.46 Aligned_cols=154 Identities=16% Similarity=0.106 Sum_probs=108.8
Q ss_pred hhHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhcCC-cHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChH
Q 012822 267 SGICEFLKLSGSSAVMLCLETWYFQILVLIAGLLD-NPELALDSLSVCMAVSGLLFMVSVGFNAAASVRVSNELGAGNPK 345 (456)
Q Consensus 267 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~~~~~~~~~~ 345 (456)
...+++.++-.|.++++....+.-++.+.-+++-. +....+++|+++..+.-++..+...+.++....+.+ +.+
T Consensus 8 ~~y~~li~F~iPLa~ts~~~dl~~qiiNagLAr~~e~~vetLAsfglA~sL~lf~~sp~~~~~~igl~~V~s-----~rs 82 (345)
T PF07260_consen 8 TSYWPLIRFFIPLAITSLAMDLGEQIINAGLARVQEDPVETLASFGLAYSLMLFFASPLSMFHHIGLVFVNS-----KRS 82 (345)
T ss_pred chHHHHHHHHHHHHHHHHHHhccHHHHHHHHhhccchHHHHHHHHHHHHHHHHHHhChhhhhHHHHHHHhcc-----hhh
Confidence 45889999999999999999999999888887743 333447899999999999999998888877776543 112
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHH-----HHHhhh-hhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCc
Q 012822 346 AAAFSVVVVTSISFIISVVFAVI-----VLALRH-VISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGW 419 (456)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~-~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~ 419 (456)
-++..... ...+...+.. .--+++ .+.+++.-|+++.+.+...+.++.+..+++++.....+++-=..+
T Consensus 83 -rr~~vl~~----~vag~v~avi~~LIa~TpLG~~li~~lhgVs~~va~~tr~a~l~L~llPfl~alr~~~qGILik~r~ 157 (345)
T PF07260_consen 83 -RRKAVLCM----AVAGAVAAVIHLLIAWTPLGNYLINDLHGVSPSVAEKTRRAFLYLTLLPFLDALRWIHQGILIKHRH 157 (345)
T ss_pred -hHHHHHHH----HHHHHHHHHHHHHHHhCchHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhhhccc
Confidence 22222222 2222222212 112222 244556678899999999999999999999999999998774566
Q ss_pred chhHHHHHHHH
Q 012822 420 QAFVAYVNIAC 430 (456)
Q Consensus 420 ~~~~~~~~~~~ 430 (456)
+......++.+
T Consensus 158 s~iV~~aSI~~ 168 (345)
T PF07260_consen 158 SWIVGSASIAD 168 (345)
T ss_pred eeEeehHHHHH
Confidence 66655555554
No 44
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=96.58 E-value=0.4 Score=42.83 Aligned_cols=121 Identities=18% Similarity=0.293 Sum_probs=76.6
Q ss_pred HHHhcCCcHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 012822 295 LIAGLLDNPELALDSLSVCMAVSGLLFMV-SVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVVFAVIVLALR 373 (456)
Q Consensus 295 ~~~~~~~~~~~av~~~~~~~~i~~~~~~i-~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (456)
++...++.++ .|.|+....+..+...+ ..++.+...- ..++|.++.++..+.......+..++..++ .
T Consensus 10 ~lar~l~~~~--~G~~~~~~s~~~~~~~~~~~g~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 78 (251)
T PF13440_consen 10 LLARYLGPED--FGIYALIFSIVSILSIVASLGLRQSLVR-----SAARDKQDIRSLLRFSLLVSLLLAVILAIL----A 78 (251)
T ss_pred HHHHHCCHHH--hHHHHHHHHHHHHHHHHHHHHHHHHHHH-----hhccCHHHHHHHHHHHHHHHHHHHHHHHHH----H
Confidence 3444445433 56999999998888876 4445444332 234666666666666555544444443333 2
Q ss_pred hhhhhcccCcHHHHHHHHhHhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHH
Q 012822 374 HVISYAFTSGEVVANAVSELCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACY 431 (456)
Q Consensus 374 ~~i~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~ 431 (456)
..+...+ ++++ ...++....+..++..........+++.+|.+.....+....
T Consensus 79 ~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 131 (251)
T PF13440_consen 79 ILIAYFF-GDPE----LFWLLLLLALAIFFSALSQLFRSILRARGRFRAYALIDIVRS 131 (251)
T ss_pred HHHHHHh-CChh----HHHHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHH
Confidence 2332333 3332 334556777778888999999999999999999988887763
No 45
>PF14667 Polysacc_synt_C: Polysaccharide biosynthesis C-terminal domain
Probab=96.22 E-value=0.011 Score=48.17 Aligned_cols=58 Identities=22% Similarity=0.323 Sum_probs=51.9
Q ss_pred HhHHHHHHHHHhhHHHHHHHHhhccCcchhHHHHHHHHHHHHHHHHHHHHHhhcCCCccee
Q 012822 393 LCPLLALTLLLNGVQPVLSGVAVGCGWQAFVAYVNIACYYIVGIPLGCLLGFKFNFGAKVK 453 (456)
Q Consensus 393 ~l~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l~~~l~~~~~~G~~G~ 453 (456)
++++++++.++.++....++++++.||+|..++.++++ .++++++.+++.+.+ |..|.
T Consensus 1 il~il~~~~~~~~l~~~~~~il~~~~k~~~~~~~~~~~-~~v~i~~~~~li~~~--G~~Ga 58 (146)
T PF14667_consen 1 ILQILALAIIFMGLSQPLGSILQAMGKTKWPFIITLIG-AIVNIILNYILIPRF--GIYGA 58 (146)
T ss_pred CHHHHHHHHHHHHHHHHHHHHHHHcCCchHHHHHHHHH-HHHHHHHHHHHHHHH--HHhHH
Confidence 36789999999999999999999999999999999888 899999999997664 77774
No 46
>PF04505 Dispanin: Interferon-induced transmembrane protein; InterPro: IPR007593 This family includes the human leukocyte antigen CD225, which is an interferon inducible transmembrane protein, and is associated with interferon induced cell growth suppression [].; GO: 0009607 response to biotic stimulus, 0016021 integral to membrane
Probab=73.59 E-value=24 Score=25.29 Aligned_cols=41 Identities=17% Similarity=0.084 Sum_probs=30.7
Q ss_pred HHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHH
Q 012822 324 SVGFNAAASVRVSNELGAGNPKAAAFSVVVVTSISFIISVV 364 (456)
Q Consensus 324 ~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (456)
..-++......+.+.+.+||.+++++.-+++.++..+-.+.
T Consensus 33 lGi~Ai~~s~kv~~~~~~Gd~~~A~~aS~~Ak~~~~ia~~~ 73 (82)
T PF04505_consen 33 LGIVAIVYSSKVRSRYAAGDYEGARRASRKAKKWSIIAIII 73 (82)
T ss_pred HHHHHheechhhHHHHHCCCHHHHHHHHHHhHHHHHHHHHH
Confidence 33455556677888899999999999999888877554444
No 47
>COG4267 Predicted membrane protein [Function unknown]
Probab=60.89 E-value=1.6e+02 Score=28.15 Aligned_cols=117 Identities=12% Similarity=0.194 Sum_probs=69.3
Q ss_pred hHHHHHHHHHHHHHHHHHHHHH-HHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHH
Q 012822 124 MLGVYMQRATFVLLATGVPVMM-VYIFCKPMLILLGESTAVASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAY 202 (456)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 202 (456)
+....+++.+.-..-+-.+.++ +....+.+..+++-++...+ ..++-.++..++......-.+.--.++-+....
T Consensus 321 kMiltlrq~i~~~~~lQ~~a~l~~flL~~~Ll~~~~lS~~~l~----lF~vd~lg~s~~i~f~~ll~i~lyfd~r~i~l~ 396 (467)
T COG4267 321 KMILTLRQGILEIMELQMLASLLCFLLADALLLWFGLSEYYLD----LFYVDVLGVSCQIVFMSLLNIFLYFDYRRIALE 396 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhh
Confidence 3334444444444444445554 47778888888887655443 355666666555555555555556667777777
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCccchhHHHHHHHHHHHHHHHHHH
Q 012822 203 ISAATLVLHLLLSWLVVYKFGAGLIGASLVLSLSWYIIVGAQFAY 247 (456)
Q Consensus 203 ~~~~~~~~~i~l~~~li~~~~~g~~g~~~a~~i~~~i~~~~~~~~ 247 (456)
.+..-.+.|-+++++.... +-+..|+ +..++..+...+....
T Consensus 397 ~t~~fli~N~ilT~i~l~l-gp~~~g~--gff~a~fl~vlv~~~~ 438 (467)
T COG4267 397 LTALFLISNGILTFIFLEL-GPGYYGV--GFFLASFLYVLVAFKS 438 (467)
T ss_pred hhhHHHHHhHHHHHHHHHh-Cccceeh--HHHHHHHHHHHHHHhh
Confidence 7777778888888877654 3444444 3444555554444433
No 48
>PF02487 CLN3: CLN3 protein; InterPro: IPR003492 Batten's disease, the juvenile variant of neuronal ceroid lipofuscionosis (NCL), is a recessively inherited disorder affecting children of 5-10 years of age. The disease is characterised by progressive loss of vision, seizures and psychomotor disturbances. Biochemically, the disease is characterised by lysosomal accumulation of hydrophobic material, mainly ATP synthase subunit C, largely in the brain but also in other tissues. The disease is fatal within a decade []. Mutations in the CLN3 gene are believed to cause Batten's disease []. The CLN3 gene, with a predicted 438-residue product, maps to chromosome p16p12.1. The gene contains at least 15 exons spanning 15kb and is highly conserved in mammals []. A 1.02kb deletion in the CLN3 gene, occurring in either one or both alleles, is found in 85% of Batten disease chromosomes causing a frameshift generating a predicted translated product of 181 amino acid residues [, ]. 22 other mutations, including deletions, insertions and point mutations, have been reported. It has been suggested that such mutations result in severely truncated CLN3 proteins, or affect its structure/conformation [, ]. CLN3 proteins, which are believed to associate in complexes, are heavily glycosylated lysosomal membrane proteins [], containing complex Asn-linked oligosaccharides []. Extensive glycosylation is important for the stability of these lysosomal proteins in the highly hydrolytic lysosomal lumen. Lysosomal sequestration of active lysosomal enzymes, transport of degraded molecules from the lysosomes, and fusion and fission between lysosomes and other organelles. The CLN3 protein is a 43kDa, highly hydrophobic, multi-transmembrane (TM), phosphorylated protein []. Hydrophobicity analysis predicts 6-9 TM segments, suggesting that CLN3 is a TM protein that may function as a chaperone or signal transducer. The majority of putative phosphorylation sites are found in the N-terminal domain, encompassing 150 residues []. Phosphorylation is believed to be important for membrane compartment interaction, in the formation of functional complexes, and in regulation and interactions with other proteins []. CLN3 contains several motifs that may undergo lipid post-translational modifications (PTMs). PTMs contribute to targeting and anchoring of modified proteins to distinct biological membranes []. There are three general classes of lipid modification: N-terminal myristoylation, C-terminal prenylation, and palmitoylation of cysteine residues. Such modifications are believed to be a common form of PTM occurring in 0.5% of all cellular proteins, including brain tissue []. The C terminus of the CLN3 contains various lipid modification sites: C435, target for prenylation; G419, target for myristoylation; and C414, target for palmitoylation []. Prenylation results in protein hydrophobicity, influences interaction with upstream regulatory proteins and downstream effectors, facilitates protein-protein interaction (multisubunit assembly) and promotes anchoring to membrane lipids. The prenylation motif, Cys-A-A-X, is highly conserved within CLN3 protein sequences of different species []. Species with known CLN3 protein homologues include: Homo sapiens, Canis familiaris, Mus musculus, Saccharomyces cerevisiae and Drosophila melanogaster.; GO: 0016020 membrane
Probab=44.86 E-value=41 Score=32.46 Aligned_cols=31 Identities=19% Similarity=0.273 Sum_probs=22.8
Q ss_pred hHHHHHHHHHHHHhhHHHHHHHHHHHHHHHH
Q 012822 41 QIASWLELKLLVRLAAPAVFVYLINNLMSLS 71 (456)
Q Consensus 41 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~i 71 (456)
.+.+.+..|.++.+.+|..+..+.+.+.+.-
T Consensus 235 ~~~k~~~~k~Ll~ymiPL~lVY~aEY~InqG 265 (402)
T PF02487_consen 235 FKEKLKRLKPLLWYMIPLFLVYFAEYFINQG 265 (402)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 3445566788888999999988888766433
No 49
>COG4176 ProW ABC-type proline/glycine betaine transport system, permease component [Amino acid transport and metabolism]
Probab=32.47 E-value=3.8e+02 Score=24.27 Aligned_cols=72 Identities=10% Similarity=-0.050 Sum_probs=40.1
Q ss_pred HHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCCchhHHHHHHHHHHHHHHHHHHHHH---hhCCccchhHHHHHH
Q 012822 164 ASAAALFVYGLIPQIFAYAVNFPIQKFLQAQSIVLPSAYISAATLVLHLLLSWLVVY---KFGAGLIGASLVLSL 235 (456)
Q Consensus 164 ~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~li~---~~~~g~~g~~~a~~i 235 (456)
++++.+-+.....+.++...-.+--++.-++.+.-+.....+....=..+--..+++ .|+.|..-..+|+++
T Consensus 91 W~~tM~TLaLVl~a~~isivIGiPlGI~~ar~~~~~~i~~PiLDlMQTmP~FVYLIPav~lFGlG~VPg~iAtvI 165 (290)
T COG4176 91 WDQTMQTLALVLTATLISIVIGIPLGIWAARSPRVYRIVRPILDLMQTMPTFVYLIPAVMLFGLGNVPGLIATVI 165 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcchHHHHHhccHHHHHHHhHHHHHHhccchHHHHHHHHHHcCCCCCceeeeeee
Confidence 444555566666666666666667777777776666555555443322222222222 346676666666655
No 50
>PF05313 Pox_P21: Poxvirus P21 membrane protein; InterPro: IPR007977 The p21 membrane protein of vaccinia virus, encoded by the A17L (or A18L) gene, has been reported to localise on the inner of the two membranes of the intracellular mature virus (IMV). It has also been shown that p21 acts as a membrane anchor for the externally located fusion protein P14 (A27L gene) [].; GO: 0016021 integral to membrane
Probab=31.61 E-value=2.8e+02 Score=23.27 Aligned_cols=27 Identities=19% Similarity=0.219 Sum_probs=18.1
Q ss_pred ccchhHHHHHHHHHHHHHHHHHHHHhc
Q 012822 225 GLIGASLVLSLSWYIIVGAQFAYILMS 251 (456)
Q Consensus 225 g~~g~~~a~~i~~~i~~~~~~~~~~~~ 251 (456)
++.|-..++.++.++.+++...|..+.
T Consensus 135 ~~s~s~~~~ti~yIiL~iLf~~Ya~nl 161 (189)
T PF05313_consen 135 SVSGSSGAYTISYIILAILFCIYAFNL 161 (189)
T ss_pred hhhHhHHHHHHHHHHHHHHHHHheeec
Confidence 344556677888888777776666554
No 51
>KOG0054 consensus Multidrug resistance-associated protein/mitoxantrone resistance protein, ABC superfamily [Secondary metabolites biosynthesis, transport and catabolism]
Probab=26.80 E-value=1e+03 Score=27.49 Aligned_cols=34 Identities=24% Similarity=0.251 Sum_probs=20.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 012822 303 PELALDSLSVCMAVSGLLFMVSVGFNAAASVRVS 336 (456)
Q Consensus 303 ~~~av~~~~~~~~i~~~~~~i~~~i~~~~~p~~~ 336 (456)
++.+..+-+..+.+..-+.+++..+++.....++
T Consensus 456 ~~~aF~slalfniLr~pl~~~P~~i~~~vqa~VS 489 (1381)
T KOG0054|consen 456 ASTAFTSLALFNILRFPLFMLPSVISQLVQAKVS 489 (1381)
T ss_pred HhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3444455555566666666677777777766554
No 52
>KOG2468 consensus Dolichol kinase [Lipid transport and metabolism]
Probab=25.71 E-value=6.5e+02 Score=24.75 Aligned_cols=38 Identities=8% Similarity=0.016 Sum_probs=29.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHH
Q 012822 318 GLLFMVSVGFNAAASVRVSNELGAGNPKAAAFSVVVVT 355 (456)
Q Consensus 318 ~~~~~i~~~i~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 355 (456)
-+.-....|++.++...+++.+|+.++.+-+|.+.-.+
T Consensus 412 ~laGiLalGiGDTmASiiG~r~G~~RW~~TkKTlEGT~ 449 (510)
T KOG2468|consen 412 LLAGILALGIGDTMASIIGKRYGRIRWSGTKKTLEGTL 449 (510)
T ss_pred hhhhheeeccchHHHHHHhhhhcceecCCCcceeehhh
Confidence 33445677999999999999999988888777666544
No 53
>PRK10739 putative antibiotic transporter; Provisional
Probab=24.64 E-value=4.5e+02 Score=22.54 Aligned_cols=54 Identities=11% Similarity=0.020 Sum_probs=34.3
Q ss_pred HHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhcccCcHHHHHH
Q 012822 332 SVRVSNELGAGNPKAAAFSVVVVTSISFIISVVFAVIVLALRHVISYAFTSGEVVANA 389 (456)
Q Consensus 332 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~ 389 (456)
.|.+-...+..+.++.|+..++....+..+ .+...++++.+.+.|+-+-+....
T Consensus 21 ipiflslt~~~~~~~r~~ia~~a~~~a~~i----ll~f~~~G~~iL~~fGIsl~afrI 74 (197)
T PRK10739 21 LPIFMSVLKHLEPKRRRAIMIRELLIALLV----MLVFLFAGEKILAFLNLRTETVSI 74 (197)
T ss_pred HHHHHHHhCCCCHHHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHhCCCHHHHHH
Confidence 455555565667777777777655554444 556777888888888655433333
No 54
>PRK09669 putative symporter YagG; Provisional
Probab=23.94 E-value=6.8e+02 Score=24.34 Aligned_cols=47 Identities=11% Similarity=-0.017 Sum_probs=21.6
Q ss_pred HHHHHhhHHHHHHHHHHHHHHHHHHHHhhc-c--ChhHHHHHHHHHHHHH
Q 012822 49 KLLVRLAAPAVFVYLINNLMSLSTRVFCGH-L--GNLELAAASLGNSGIQ 95 (456)
Q Consensus 49 ~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~--g~~~~~~~~~~~~i~~ 95 (456)
++-+.++..-...+...........++... + ++..+|..-...++..
T Consensus 9 ~~~~~yg~g~~~~~~~~~~~~~~l~~~~t~~~gls~~~~g~i~~i~~i~d 58 (444)
T PRK09669 9 KDKIGYGLGDTACNLVWQTVMLFLAYFYTDVFGLSAAIMGTMFLVVRVLD 58 (444)
T ss_pred HHHHhhcchhhhhhHHHHHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 445556666555555544444444444433 3 3444444433333333
No 55
>PF04505 Dispanin: Interferon-induced transmembrane protein; InterPro: IPR007593 This family includes the human leukocyte antigen CD225, which is an interferon inducible transmembrane protein, and is associated with interferon induced cell growth suppression [].; GO: 0009607 response to biotic stimulus, 0016021 integral to membrane
Probab=22.98 E-value=2.9e+02 Score=19.72 Aligned_cols=31 Identities=19% Similarity=0.163 Sum_probs=23.1
Q ss_pred HHHHhhhcCCCcchHHHHHHHHHHHHHHHHH
Q 012822 111 TLCGQAYGAGRYEMLGVYMQRATFVLLATGV 141 (456)
Q Consensus 111 ~~vs~~~g~~~~~~~~~~~~~~~~~~~~~~~ 141 (456)
..+-+.+.+||.+.+++.-+++..++.+-.+
T Consensus 42 ~kv~~~~~~Gd~~~A~~aS~~Ak~~~~ia~~ 72 (82)
T PF04505_consen 42 SKVRSRYAAGDYEGARRASRKAKKWSIIAII 72 (82)
T ss_pred hhhHHHHHCCCHHHHHHHHHHhHHHHHHHHH
Confidence 4566677789999999988888777754433
Done!